[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_c24da647-163c-4233-88eb-007e8b5b5585":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:c24da647-163c-4233-88eb-007e8b5b5585,\"}":98},{"code":4,"data":5,"meta":22},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":24,"manageAffiliations":31,"indexDatabases":46,"url":81,"thumbnailPath":22,"statistic":82,"gsStatistic":22,"type":22,"analyzePriority":22},"c24da647-163c-4233-88eb-007e8b5b5585","2023-05-29T11:36:24.756+00:00","2025-11-21T09:52:38.056+00:00",[],"European-Urology-Focus",{"country":12,"issn":14,"title":16,"introduce":18},{"VOID":13},"NL",{"VOID":15},"24054569",{"EN":17},"European Urology Focus",{"EN":19},"The aim of European Urology Focus (EU Focus) is to encompass the whole spectrum of urology. The journal publishes papers on a wide range of urological issues such as oncology, functional urology, reconstructive urology, laparoscopy, robotic surgery, endourology, female urology, andrology, paediatric urology and sexual medicine. The editorial team welcomes basic and translational research articles in the field of urological diseases. Besides original research articles and systematic reviews, which are the backbone of the journal, EU Focus publishes “Point of Focus” debates which cover controversial topics from a pro\u002Fcon standpoint. The journal also publishes “Clinical Trial Updates” focusing on an ongoing trial, and the “Grey Zone”, which sheds light on areas for which guideline recommendations are difficult to make, because of the absence of data. In addition, the “Clinical Consultation Guide” discusses hot topics from a clinician’s point of view. The journal also includes “Mini-Reviews”, which allow the summary of a certain topic in no more than 1000 words.","PUBLISHER","PENDING",null,21,[25],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":27,"label":28,"description":30,"parentId":22,"standard":22,"scholarHubFieldId":22},"8e32f7cd-3445-43a4-981f-c8e55ee3064b",[],{"EN":29},"Urology",{},[32,39],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":34,"slug":22,"properties":35,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":38,"statistic":22},"c204a4fd-ec04-47ff-9c5b-5d693c99cecf",[],{"title":36},{"EN":37},"Elsevier BV",[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":41,"slug":22,"properties":42,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":45,"statistic":22},"c749757b-dddf-4e6f-9697-b9c441adc06c",[],{"title":43},{"EN":44},"Elsevier",[],[47,64],{"id":48,"indexDatabase":49,"url":61,"indexYears":22,"academicFieldIds":62,"indexDatabaseRanking":22},"3c77b29a-b511-40bc-b069-b79f707f93be",{"id":50,"createTime":22,"updateTime":22,"relativeEntities":51,"label":52,"description":54,"key":57,"publicationTags":58,"standard":22},"a4921856-b128-4d9f-8f1f-e80813d3bbd4",[],{"EN":53,"VI":53},"ISI\u002FSCIE - Science Citation Index Expanded",{"EN":55,"VI":56},"SCIE database","Cơ sở dữ liệu SCIE","scie",[59,60],"SCIE","ISI","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002Fnull",[63],"89bd3143-34da-4e0c-a662-528d683c514f",{"id":65,"indexDatabase":66,"url":76,"indexYears":77,"academicFieldIds":78,"indexDatabaseRanking":80},"2beb3ea8-fd3b-4d3b-b869-0918c29824d7",{"id":67,"createTime":22,"updateTime":22,"relativeEntities":68,"label":69,"description":71,"key":73,"publicationTags":74,"standard":22},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9",[],{"EN":70,"VI":70},"Scopus - Elsevier",{"EN":70,"VI":72},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[75],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F21100406908","2015-2025",[79],"45560ae3-6e73-4562-b98a-3bad7e554cef","SCOPUS__Q1","https:\u002F\u002Fwww.eu-focus.europeanurology.com\u002F",{"impactFactor":83,"impactFactorByYear":84,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":86,"totalCitation":83,"totalCitationByYear":96,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":97,"hindexLast5Year":83,"hindex":83},0,{},1316,{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},23,77,87,170,160,171,201,246,181,{},{},{"meta":99,"data":101},{"total":100},"567",[102,375,726,843,1164,1500,1861,2477,2599,2946],{"id":103,"createTime":104,"updateTime":105,"relativeEntities":106,"slug":107,"properties":108,"entityType":117,"verifyStatus":118,"verifyTime":119,"verifyNote":120,"languages":22,"translateLanguages":22,"viewCount":83,"primaryUrl":121,"fullTextUrl":22,"authors":122,"publicationType":318,"publisherRelationship":319,"citationCount":83,"citationInfo":367,"publishDate":370,"publishYear":368,"citationAnalyzeStatus":371,"lastCitationAnalyze":372,"indexDatabases":373,"openAccess":22,"references":22,"isForceReanalyzing":374},"298bc796-ec44-4605-8124-0e5fb63732d8","2024-01-03T12:14:12.395+00:00","2026-07-18T16:50:35.970+00:00",[],"Simplified-PADUA-Renal-SPARE-Nephrometry-Scoring-System-External-Validation-Interobserver-Variability-and-Comparison-with-RENAL-and-PADUA-in-a-Single-center-Robotic-Partial-Nephrectomy-Series",{"title":109,"gsPaper":111,"references":113,"doi":115},{"EN":110},"Simplified PADUA Renal (SPARE) Nephrometry Scoring System: External Validation, Interobserver Variability, and Comparison with RENAL and PADUA in a Single-center Robotic Partial Nephrectomy Series",{"VOID":112},"[\"1627774435579984132\"]",{"VOID":114},"Grivas, 2019, Robot-assisted versus open partial nephrectomy: comparison of outcomes. A systematic review, Minerva Urol Nefrol, 71, 113, 10.23736\u002FS0393-2249.19.03391-5\nVeccia, 2020, Predictive value of nephrometry scores in nephron-sparing surgery: a systematic review and meta-analysis, Eur Urol Focus, 6, 490, 10.1016\u002Fj.euf.2019.11.004\nKutikov, 2009, The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth, J Urol, 182, 844, 10.1016\u002Fj.juro.2009.05.035\nFicarra, 2009, Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery, Eur Urol, 56, 786, 10.1016\u002Fj.eururo.2009.07.040\nSchiavina, 2017, PADUA and R.E.N.A.L. nephrometry scores correlate with perioperative outcomes of robot-assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database, BJU Int, 119, 456, 10.1111\u002Fbju.13628\nGupta, 2019, Comparison of RENAL, PADUA, CSA, and PAVP nephrometry scores in predicting functional outcomes after partial nephrectomy, Urology, 124, 160, 10.1016\u002Fj.urology.2018.03.055\nSterzik, 2019, Improved prediction of nephron-sparing surgery versus radical nephrectomy by the optimized R.E.N.A.L. score in patients undergoing surgery for renal masses, Minerva Urol Nefrol, 71, 249, 10.23736\u002FS0393-2249.18.03134-X\nBenadiba, 2015, Are urologists and radiologists equally effective in determining the RENAL Nephrometry score?, Ann Surg Oncol, 22, 1618, 10.1245\u002Fs10434-014-4152-1\nMonn, 2014, R.E.N.A.L. Nephrometry scoring: how well correlated are urologist, radiologist, and collaborator scores?, J Endourol, 28, 1006, 10.1089\u002Fend.2014.0166\nFicarra, 2019, The Simplified PADUA REnal (SPARE) nephrometry system: a novel classification of parenchymal renal tumours suitable for partial nephrectomy, BJU Int, 124, 621, 10.1111\u002Fbju.14772\nAssel, 2019, Guidelines for reporting of statistics for clinical research in urology, BJU Int, 123, 401, 10.1111\u002Fbju.14640\nMcHugh, 2012, Interrater reliability: the kappa statistic, Biochem Med (Zagreb), 22, 276, 10.11613\u002FBM.2012.031\nCampbell, 2017, Renal mass and localized renal cancer: AUA guideline, J Urol, 198, 520, 10.1016\u002Fj.juro.2017.04.100\nLjungberg, 2019, European Association of Urology guidelines on renal cell carcinoma: the 2019 update, Eur Urol, 75, 799, 10.1016\u002Fj.eururo.2019.02.011\nVilaseca A, Guglielmetti G, Vertosick EA, et al. Value of partial nephrectomy for renal cortical tumors of cT2 or greater stage: a risk-benefit analysis of renal function preservation versus increased postoperative morbidity. Eur Urol Oncol. In press. https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.euo.2019.04.003.\nLi, 2019, Partial nephrectomy versus radical nephrectomy for cT2 or greater renal tumors: a systematic review and meta-analysis, Minerva Urol Nefrol, 71, 435, 10.23736\u002FS0393-2249.19.03470-2\nScosyrev, 2014, Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904, Eur Urol, 65, 372, 10.1016\u002Fj.eururo.2013.06.044\nHadjipavlou, 2016, Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons nephrectomy audit, BJU Int, 117, 62, 10.1111\u002Fbju.13114\nBorghesi, 2013, Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses, World J Urol, 31, 499, 10.1007\u002Fs00345-013-1095-2\nSchiavina, 2015, A snapshot of nephron-sparing surgery in Italy: a prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project), Eur J Surg Oncol, 41, 346, 10.1016\u002Fj.ejso.2014.12.001\nDahlkamp, 2019, Interdisciplinary comparison of PADUA and R.E.N.A.L. scoring systems for prediction of conversion to nephrectomy in patients with renal mass scheduled for nephron sparing surgery, J Urol, 202, 890, 10.1097\u002FJU.0000000000000361\nWeight, 2011, A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes, J Urol, 186, 1223, 10.1016\u002Fj.juro.2011.05.052\nAlvim, 2018, Performance prediction for surgical outcomes in partial nephrectomy using nephrometry scores: a comparison of arterial based complexity (ABC), RENAL, and PADUA systems, Eur Urol Oncol, 1, 428, 10.1016\u002Fj.euo.2018.05.004\nAntonelli, 2018, External validation of the arterial-based complexity score and first head-to-head comparison with the R.E.N.A.L. and PADUA scores and C-index, Clin Genitourin Cancer, 16, e595, 10.1016\u002Fj.clgc.2017.10.018",{"VOID":116},"10.1016\u002Fj.euf.2020.05.016","PUBLICATION","VERIFIED","2024-05-27T23:28:54.595+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS2405456920301516",[123,139,163,195,209,225,239,262,276,290,304],{"id":124,"sortIndex":83,"researcher":22,"roles":125,"affiliations":127,"properties":136,"displayName":138,"givenName":22,"familyName":22},"a953c74e-757d-4ff0-a661-b9bd4d417bfa",[126],"AUTHOR",[128],{"id":129,"sortIndex":83,"affiliation":130,"properties":22},"d05b0148-6881-4310-89ef-c10c8f4d014a",{"id":129,"createTime":22,"updateTime":22,"relativeEntities":131,"slug":22,"properties":132,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":135,"statistic":22},[],{"title":133},{"VI":134},"Division of Urology, VCU Health System, Richmond, VA, USA",[],{"title":137},{"VI":138},"Samuel Weprin",{"id":140,"sortIndex":141,"researcher":22,"roles":142,"affiliations":143,"properties":158,"displayName":160,"givenName":22,"familyName":22},"bbbcf783-8516-4032-9a1c-e052cefffb63",1,[126],[144,150],{"id":129,"sortIndex":83,"affiliation":145,"properties":22},{"id":129,"createTime":22,"updateTime":22,"relativeEntities":146,"slug":22,"properties":147,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":149,"statistic":22},[],{"title":148},{"VI":134},[],{"id":151,"sortIndex":141,"affiliation":152,"properties":22},"d006cc45-1269-4a16-ae54-8784813e40ff",{"id":151,"createTime":22,"updateTime":22,"relativeEntities":153,"slug":22,"properties":154,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":157,"statistic":22},[],{"title":155},{"VI":156},"Urology and Renal Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy",[],{"title":159,"gsAuthor":161},{"VI":160},"Ugo Falagario",{"VOID":162},"[\"7g7BumQAAAAJ\"]",{"id":164,"sortIndex":165,"researcher":22,"roles":166,"affiliations":167,"properties":190,"displayName":192,"givenName":22,"familyName":22},"ae1a6c3f-3be8-4fc2-a546-63886798b641",2,[126],[168,174,182],{"id":129,"sortIndex":83,"affiliation":169,"properties":22},{"id":129,"createTime":22,"updateTime":22,"relativeEntities":170,"slug":22,"properties":171,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":173,"statistic":22},[],{"title":172},{"VI":134},[],{"id":175,"sortIndex":141,"affiliation":176,"properties":22},"1c47b57a-6361-484e-b84d-3f3335f83808",{"id":175,"createTime":22,"updateTime":22,"relativeEntities":177,"slug":22,"properties":178,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":181,"statistic":22},[],{"title":179},{"VI":180},"Urology Unit, ASST Spedali Civili Hospital, Brescia, Italy",[],{"id":183,"sortIndex":165,"affiliation":184,"properties":22},"27caaab7-98f6-4e50-8cc3-f859210974f7",{"id":183,"createTime":22,"updateTime":22,"relativeEntities":185,"slug":22,"properties":186,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":189,"statistic":22},[],{"title":187},{"VI":188},"Department of Medical and Surgical Specialties, Radiological Science and Public Health, University of Brescia, Brescia, Italy",[],{"title":191,"gsAuthor":193},{"VI":192},"Alessandro Veccia",{"VOID":194},"[\"kN7c09wAAAAJ\"]",{"id":196,"sortIndex":197,"researcher":22,"roles":198,"affiliations":199,"properties":206,"displayName":208,"givenName":22,"familyName":22},"32aa5598-99f1-43e1-8062-54a54a63c0f1",3,[126],[200],{"id":129,"sortIndex":83,"affiliation":201,"properties":22},{"id":129,"createTime":22,"updateTime":22,"relativeEntities":202,"slug":22,"properties":203,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":205,"statistic":22},[],{"title":204},{"VI":134},[],{"title":207},{"VI":208},"Naveen Nandanan",{"id":210,"sortIndex":211,"researcher":22,"roles":212,"affiliations":213,"properties":222,"displayName":224,"givenName":22,"familyName":22},"5ca2fea3-464a-4968-a046-d6aae6dfc8a6",4,[126],[214],{"id":215,"sortIndex":83,"affiliation":216,"properties":22},"8af6514e-29cd-4168-8fe0-c72e0524679b",{"id":215,"createTime":22,"updateTime":22,"relativeEntities":217,"slug":22,"properties":218,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":221,"statistic":22},[],{"title":219},{"VI":220},"Department of Radiology, VCU Health, Richmond, VA, USA",[],{"title":223},{"VI":224},"Dow Emerson",{"id":226,"sortIndex":227,"researcher":22,"roles":228,"affiliations":229,"properties":236,"displayName":238,"givenName":22,"familyName":22},"896bd6ca-c485-4834-bd46-7fd6d827ce29",5,[126],[230],{"id":215,"sortIndex":83,"affiliation":231,"properties":22},{"id":215,"createTime":22,"updateTime":22,"relativeEntities":232,"slug":22,"properties":233,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":235,"statistic":22},[],{"title":234},{"VI":220},[],{"title":237},{"VI":238},"Christopher Ovanez",{"id":240,"sortIndex":241,"researcher":22,"roles":242,"affiliations":243,"properties":259,"displayName":261,"givenName":22,"familyName":22},"d0002385-9696-42c1-a329-2b24ae8a40f9",6,[126],[244,250],{"id":129,"sortIndex":83,"affiliation":245,"properties":22},{"id":129,"createTime":22,"updateTime":22,"relativeEntities":246,"slug":22,"properties":247,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":249,"statistic":22},[],{"title":248},{"VI":134},[],{"id":251,"sortIndex":141,"affiliation":252,"properties":258},"a6eca342-53ca-4ee1-b76d-79483c3e9008",{"id":251,"createTime":22,"updateTime":22,"relativeEntities":253,"slug":22,"properties":254,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":257,"statistic":22},[],{"title":255},{"VI":256},"Division of Urology, Hospital das Clinicas, University of Sao Paulo Medical School, São Paulo, Brazil",[],{},{"title":260},{"VI":261},"Emanuel V. Albuquerque",{"id":263,"sortIndex":264,"researcher":22,"roles":265,"affiliations":266,"properties":273,"displayName":275,"givenName":22,"familyName":22},"de4e6795-8647-484f-8f84-b3064ed0d215",7,[126],[267],{"id":129,"sortIndex":83,"affiliation":268,"properties":22},{"id":129,"createTime":22,"updateTime":22,"relativeEntities":269,"slug":22,"properties":270,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":272,"statistic":22},[],{"title":271},{"VI":134},[],{"title":274},{"VI":275},"Eduardo B. Zukovski",{"id":277,"sortIndex":278,"researcher":22,"roles":279,"affiliations":280,"properties":287,"displayName":289,"givenName":22,"familyName":22},"00019276-2f5f-4c27-9a30-12a2516226a8",8,[126],[281],{"id":215,"sortIndex":83,"affiliation":282,"properties":22},{"id":215,"createTime":22,"updateTime":22,"relativeEntities":283,"slug":22,"properties":284,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":286,"statistic":22},[],{"title":285},{"VI":220},[],{"title":288},{"VI":289},"Ryan Clayton",{"id":291,"sortIndex":292,"researcher":22,"roles":293,"affiliations":294,"properties":301,"displayName":303,"givenName":22,"familyName":22},"ae28ea26-b39f-474c-9164-3f092a3d075a",9,[126],[295],{"id":129,"sortIndex":83,"affiliation":296,"properties":22},{"id":129,"createTime":22,"updateTime":22,"relativeEntities":297,"slug":22,"properties":298,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":300,"statistic":22},[],{"title":299},{"VI":134},[],{"title":302},{"VI":303},"Lance Hampton",{"id":305,"sortIndex":306,"researcher":22,"roles":307,"affiliations":308,"properties":315,"displayName":317,"givenName":22,"familyName":22},"a4f344c7-2ce6-4691-8763-31b8d56d8899",10,[126],[309],{"id":129,"sortIndex":83,"affiliation":310,"properties":22},{"id":129,"createTime":22,"updateTime":22,"relativeEntities":311,"slug":22,"properties":312,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":314,"statistic":22},[],{"title":313},{"VI":134},[],{"title":316},{"VI":317},"Riccardo Autorino","ARTICLE",{"url":121,"publisher":320,"properties":362},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":321,"slug":10,"properties":322,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":326,"manageAffiliations":331,"indexDatabases":342,"url":81,"thumbnailPath":22,"statistic":357,"gsStatistic":22,"type":22,"analyzePriority":22},[],{"issn":323,"title":324,"country":325},{"VOID":15},{"EN":17},{"VOID":13},[327],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":328,"label":329,"description":330,"parentId":22,"standard":22,"scholarHubFieldId":22},[],{"EN":29},{},[332,337],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":333,"slug":22,"properties":334,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":336,"statistic":22},[],{"title":335},{"EN":37},[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":338,"slug":22,"properties":339,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":341,"statistic":22},[],{"title":340},{"EN":44},[],[343,350],{"id":48,"indexDatabase":344,"url":61,"indexYears":22,"academicFieldIds":349,"indexDatabaseRanking":22},{"id":50,"createTime":22,"updateTime":22,"relativeEntities":345,"label":346,"description":347,"key":57,"publicationTags":348,"standard":22},[],{"EN":53,"VI":53},{"EN":55,"VI":56},[59,60],[63],{"id":65,"indexDatabase":351,"url":76,"indexYears":77,"academicFieldIds":356,"indexDatabaseRanking":80},{"id":67,"createTime":22,"updateTime":22,"relativeEntities":352,"label":353,"description":354,"key":73,"publicationTags":355,"standard":22},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79],{"impactFactor":83,"impactFactorByYear":358,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":359,"totalCitation":83,"totalCitationByYear":360,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":361,"hindexLast5Year":83,"hindex":83},{},{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},{},{},{"pages":363,"volume":365},{"VOID":364},"591-597",{"VOID":366},"7",{"total":83,"publishYear":368,"statisticByYear":369},2021,{},"2021-05-01","DONE_ANALYZE_CITATION","2026-07-18T16:50:35.969+00:00",[59,80],false,{"id":376,"createTime":377,"updateTime":378,"relativeEntities":379,"slug":380,"properties":381,"entityType":117,"verifyStatus":118,"verifyTime":390,"verifyNote":120,"languages":22,"translateLanguages":22,"viewCount":83,"primaryUrl":391,"fullTextUrl":22,"authors":392,"publicationType":318,"publisherRelationship":672,"citationCount":720,"citationInfo":721,"publishDate":724,"publishYear":722,"citationAnalyzeStatus":371,"lastCitationAnalyze":378,"indexDatabases":725,"openAccess":22,"references":22,"isForceReanalyzing":374},"456eb39d-fa50-4786-8095-898951b0bceb","2023-12-28T16:04:01.885+00:00","2026-07-16T03:55:38.594+00:00",[],"A-New-Model-to-Predict-Benign-Histology-in-Residual-Retroperitoneal-Masses-After-Chemotherapy-in-Nonseminoma",{"title":382,"gsPaper":384,"references":386,"doi":388},{"EN":383},"A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma",{"VOID":385},"[\"8438925125319697910\"]",{"VOID":387},"Le Cornet, 2014, Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data, Eur J Cancer, 50, 831, 10.1016\u002Fj.ejca.2013.11.035\nNational Cancer Institute. SEER cancer stat facts: testiscancer 2017.\nHorwich, 2006, Testicular germ-cell cancer, Lancet, 367, 754, 10.1016\u002FS0140-6736(06)68305-0\nFerlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, E359, 10.1002\u002Fijc.29210\nAlbers, 2012, EAU guidelines on testicular cancer: 2011 update. European Association of Urology, Acta Urol Esp, 36, 127, 10.1016\u002Fj.acuro.2011.06.017\nKollmannsberger, 2010, Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery, J Clin Oncol, 28, 537, 10.1200\u002FJCO.2009.23.0755\nJewett, 2011, Words of wisdom. Re: management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery, Eur Urol, 59, 880, 10.1016\u002Fj.eururo.2011.02.013\nKrege, 2008, European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II, Eur Urol, 53, 497, 10.1016\u002Fj.eururo.2007.12.025\nSteyerberg, 1995, Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups, J Clin Oncol, 13, 1177, 10.1200\u002FJCO.1995.13.5.1177\nKrege, 2008, European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I, Eur Urol, 53, 478, 10.1016\u002Fj.eururo.2007.12.024\nBeck, 2006, Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancer, World J Urol, 24, 267, 10.1007\u002Fs00345-006-0060-8\nAlbers, 2004, Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group, J Urol, 171, 1835, 10.1097\u002F01.ju.0000119121.36427.09\nHeidenreich, 2009, Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection, Eur Urol, 55, 217, 10.1016\u002Fj.eururo.2008.09.027\nVergouwe, 2001, Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer, J Urol, 165, 84, 10.1097\u002F00005392-200101000-00021\nOnozawa, 2004, Clinical parameters that predict histology of postchemotherapy retroperitoneal lymph node mass in testicular cancer, Int J Urol, 11, 535, 10.1111\u002Fj.1442-2042.2004.00832.x\nOldenburg, 2003, Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses, J Clin Oncol, 21, 3310, 10.1200\u002FJCO.2003.03.184\nVergouwe, 2007, Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients, Eur Urol, 51, 424, 10.1016\u002Fj.eururo.2006.06.047\nPunjani, 2016, Validation of a prediction model for avoiding post-chemotherapy retroperitoneal lymphadenectomy in patients with metastatic non-seminomatous cancer, Can Urol Assoc J, 10, 260, 10.5489\u002Fcuaj.3558\nNayan, 2016, Medication use and survival in diabetic patients with kidney cancer: a population-based cohort study, Pharmacol Res, 113, 468, 10.1016\u002Fj.phrs.2016.09.027\nRoyston, 2005, Building multivariable regression models with continuous covariates in clinical epidemiology—with an emphasis on fractional polynomials, Methods Inf Med, 44, 561, 10.1055\u002Fs-0038-1634008\nAustin, 2014, Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs, Pharmacoepidemiol Drug Saf, 23, 819, 10.1002\u002Fpds.3607\nHarrell, 1982, Evaluating the yield of medical tests, JAMA, 247, 2543, 10.1001\u002Fjama.1982.03320430047030\nHosmer, 1989\nRavi, 2014, A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor, Ann Oncol, 25, 331, 10.1093\u002Fannonc\u002Fmdt425\nSheinfeld, 2002, The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies, Semin Urol Oncol, 20, 262, 10.1053\u002Fsuro.2002.36977\nToner, 1990, Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection, J Clin Oncol, 8, 1683, 10.1200\u002FJCO.1990.8.10.1683\nSchultz, 1989, Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience, J Clin Oncol, 7, 1497, 10.1200\u002FJCO.1989.7.10.1497\nEinhorn, 1997, Do all germ cell tumor patients with residual masses in multiple sites require postchemotherapy resections?, J Clin Oncol, 15, 409, 10.1200\u002FJCO.1997.15.1.409\nDebono, 1997, Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors, J Clin Oncol, 15, 1455, 10.1200\u002FJCO.1997.15.4.1455\nFossa, 1992, Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?, J Clin Oncol, 10, 569, 10.1200\u002FJCO.1992.10.4.569",{"VOID":389},"10.1016\u002Fj.euf.2018.01.015","2024-05-09T14:14:21.086+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS2405456918300166",[393,410,425,440,455,468,481,496,511,526,539,554,570,584,598,614,628,644,658],{"id":394,"sortIndex":83,"researcher":22,"roles":395,"affiliations":396,"properties":405,"displayName":407,"givenName":22,"familyName":22},"f4c75a40-dc1a-48b2-a834-9ab4543c96e1",[126],[397],{"id":398,"sortIndex":83,"affiliation":399,"properties":22},"e1a00b22-bfc5-4216-982a-38272c408c20",{"id":398,"createTime":22,"updateTime":22,"relativeEntities":400,"slug":22,"properties":401,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":404,"statistic":22},[],{"title":402},{"VI":403},"Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada",[],{"title":406,"gsAuthor":408},{"VI":407},"Ricardo Leão",{"VOID":409},"[\"m8TtYnIAAAAJ\"]",{"id":411,"sortIndex":141,"researcher":22,"roles":412,"affiliations":413,"properties":420,"displayName":422,"givenName":22,"familyName":22},"84b4f41c-5a9d-461a-96aa-5d0760ac08f0",[126],[414],{"id":398,"sortIndex":83,"affiliation":415,"properties":22},{"id":398,"createTime":22,"updateTime":22,"relativeEntities":416,"slug":22,"properties":417,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":419,"statistic":22},[],{"title":418},{"VI":403},[],{"title":421,"gsAuthor":423},{"VI":422},"Madhur Nayan",{"VOID":424},"[\"8x0bQEcAAAAJ\"]",{"id":426,"sortIndex":165,"researcher":22,"roles":427,"affiliations":428,"properties":437,"displayName":439,"givenName":22,"familyName":22},"39380eb2-eacc-4fb9-a390-63647ee7f80f",[126],[429],{"id":430,"sortIndex":83,"affiliation":431,"properties":22},"76e46149-a86b-4f74-8ddf-f8214f9c64ef",{"id":430,"createTime":22,"updateTime":22,"relativeEntities":432,"slug":22,"properties":433,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":436,"statistic":22},[],{"title":434},{"VI":435},"Division of Urology, Western University and London Health Sciences Centre, London, ON, Canada",[],{"title":438},{"VI":439},"Nahid Punjani",{"id":441,"sortIndex":197,"researcher":22,"roles":442,"affiliations":443,"properties":450,"displayName":452,"givenName":22,"familyName":22},"169cf624-28d2-49bf-863f-11ad6c7181d9",[126],[444],{"id":398,"sortIndex":83,"affiliation":445,"properties":22},{"id":398,"createTime":22,"updateTime":22,"relativeEntities":446,"slug":22,"properties":447,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":449,"statistic":22},[],{"title":448},{"VI":403},[],{"title":451,"gsAuthor":453},{"VI":452},"Michael A.S. Jewett",{"VOID":454},"[\"Aynug_8AAAAJ\"]",{"id":456,"sortIndex":211,"researcher":22,"roles":457,"affiliations":458,"properties":465,"displayName":467,"givenName":22,"familyName":22},"06088587-6f1f-41e9-8d79-c38a7530815d",[126],[459],{"id":398,"sortIndex":83,"affiliation":460,"properties":22},{"id":398,"createTime":22,"updateTime":22,"relativeEntities":461,"slug":22,"properties":462,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":464,"statistic":22},[],{"title":463},{"VI":403},[],{"title":466},{"VI":467},"Kamel Fadaak",{"id":469,"sortIndex":227,"researcher":22,"roles":470,"affiliations":471,"properties":478,"displayName":480,"givenName":22,"familyName":22},"d3ce2efe-6065-464f-a72a-21ad0600cb96",[126],[472],{"id":398,"sortIndex":83,"affiliation":473,"properties":22},{"id":398,"createTime":22,"updateTime":22,"relativeEntities":474,"slug":22,"properties":475,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":477,"statistic":22},[],{"title":476},{"VI":403},[],{"title":479},{"VI":480},"Juan Garisto",{"id":482,"sortIndex":241,"researcher":22,"roles":483,"affiliations":484,"properties":493,"displayName":495,"givenName":22,"familyName":22},"9e226108-2ce3-4b5d-a5e0-764eb534cf12",[126],[485],{"id":486,"sortIndex":83,"affiliation":487,"properties":22},"52116101-0065-4cb8-9a3b-11c47ab9f5f2",{"id":486,"createTime":22,"updateTime":22,"relativeEntities":488,"slug":22,"properties":489,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":492,"statistic":22},[],{"title":490},{"VI":491},"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Department of Medicine, University of Toronto, Toronto, ON, Canada",[],{"title":494},{"VI":495},"Jeremy Lewin",{"id":497,"sortIndex":264,"researcher":22,"roles":498,"affiliations":499,"properties":508,"displayName":510,"givenName":22,"familyName":22},"dbafeaa3-10b6-40d8-a21e-e0476328cc4b",[126],[500],{"id":501,"sortIndex":83,"affiliation":502,"properties":22},"5da8f521-3ff7-4f4d-917d-d167fc3330c6",{"id":501,"createTime":22,"updateTime":22,"relativeEntities":503,"slug":22,"properties":504,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":507,"statistic":22},[],{"title":505},{"VI":506},"Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada",[],{"title":509},{"VI":510},"Eshetu G. Atenafu",{"id":512,"sortIndex":278,"researcher":22,"roles":513,"affiliations":514,"properties":523,"displayName":525,"givenName":22,"familyName":22},"c32921fe-948d-4e80-b04a-05966c407c6d",[126],[515],{"id":516,"sortIndex":83,"affiliation":517,"properties":22},"8e4244b6-e4d2-4f4c-ad0c-717a378eaa2d",{"id":516,"createTime":22,"updateTime":22,"relativeEntities":518,"slug":22,"properties":519,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":522,"statistic":22},[],{"title":520},{"VI":521},"Department of Pathology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada",[],{"title":524},{"VI":525},"Joan Sweet",{"id":527,"sortIndex":292,"researcher":22,"roles":528,"affiliations":529,"properties":536,"displayName":538,"givenName":22,"familyName":22},"5dedd9fe-5913-4648-8c4f-e2af2d2d73cb",[126],[530],{"id":398,"sortIndex":83,"affiliation":531,"properties":22},{"id":398,"createTime":22,"updateTime":22,"relativeEntities":532,"slug":22,"properties":533,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":535,"statistic":22},[],{"title":534},{"VI":403},[],{"title":537},{"VI":538},"Lynn Anson-Cartwright",{"id":540,"sortIndex":306,"researcher":22,"roles":541,"affiliations":542,"properties":551,"displayName":553,"givenName":22,"familyName":22},"b0571c89-1f57-4d58-82b7-8a2c692577b5",[126],[543],{"id":544,"sortIndex":83,"affiliation":545,"properties":22},"9f4154d7-ca1e-4a19-814a-f49302eac04d",{"id":544,"createTime":22,"updateTime":22,"relativeEntities":546,"slug":22,"properties":547,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":550,"statistic":22},[],{"title":548},{"VI":549},"Department of Urology, Turku University Hospital, Turku, Finland",[],{"title":552},{"VI":553},"Peter Boström",{"id":555,"sortIndex":556,"researcher":22,"roles":557,"affiliations":558,"properties":567,"displayName":569,"givenName":22,"familyName":22},"a7fb5061-bdc1-418d-a68c-25cb2e4a17e8",11,[126],[559],{"id":560,"sortIndex":83,"affiliation":561,"properties":22},"3a86cd83-207f-42fe-8b43-e980c7909369",{"id":560,"createTime":22,"updateTime":22,"relativeEntities":562,"slug":22,"properties":563,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":566,"statistic":22},[],{"title":564},{"VI":565},"department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada",[],{"title":568},{"VI":569},"Peter Chung",{"id":571,"sortIndex":572,"researcher":22,"roles":573,"affiliations":574,"properties":581,"displayName":583,"givenName":22,"familyName":22},"67a0d85e-b368-473f-960e-a5428cba1468",12,[126],[575],{"id":560,"sortIndex":83,"affiliation":576,"properties":22},{"id":560,"createTime":22,"updateTime":22,"relativeEntities":577,"slug":22,"properties":578,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":580,"statistic":22},[],{"title":579},{"VI":565},[],{"title":582},{"VI":583},"Padraig Warde",{"id":585,"sortIndex":586,"researcher":22,"roles":587,"affiliations":588,"properties":595,"displayName":597,"givenName":22,"familyName":22},"1abaecf9-5e36-4717-8817-7de0801f9d5e",13,[126],[589],{"id":486,"sortIndex":83,"affiliation":590,"properties":22},{"id":486,"createTime":22,"updateTime":22,"relativeEntities":591,"slug":22,"properties":592,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":594,"statistic":22},[],{"title":593},{"VI":491},[],{"title":596},{"VI":597},"Philippe L. Bedard",{"id":599,"sortIndex":600,"researcher":22,"roles":601,"affiliations":602,"properties":611,"displayName":613,"givenName":22,"familyName":22},"04d0ce49-30e3-4394-a982-0dc0daa872ec",14,[126],[603],{"id":604,"sortIndex":83,"affiliation":605,"properties":22},"41235f35-6bbd-4d77-97da-f09d4d25f0ea",{"id":604,"createTime":22,"updateTime":22,"relativeEntities":606,"slug":22,"properties":607,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":610,"statistic":22},[],{"title":608},{"VI":609},"Division of Urology, UT Southwestern Medical Center, Dallas, TX, USA",[],{"title":612},{"VI":613},"Aditya Bagrodia",{"id":615,"sortIndex":616,"researcher":22,"roles":617,"affiliations":618,"properties":625,"displayName":627,"givenName":22,"familyName":22},"5be99950-195f-432d-829b-0da450a47bf3",15,[126],[619],{"id":604,"sortIndex":83,"affiliation":620,"properties":22},{"id":604,"createTime":22,"updateTime":22,"relativeEntities":621,"slug":22,"properties":622,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":624,"statistic":22},[],{"title":623},{"VI":609},[],{"title":626},{"VI":627},"Yuval Freifeld",{"id":629,"sortIndex":630,"researcher":22,"roles":631,"affiliations":632,"properties":641,"displayName":643,"givenName":22,"familyName":22},"653b6948-26cf-4d63-bc24-d3a77835fa03",16,[126],[633],{"id":634,"sortIndex":83,"affiliation":635,"properties":22},"c64c6efa-dd4d-4ccc-8a90-92e5a3828ca3",{"id":634,"createTime":22,"updateTime":22,"relativeEntities":636,"slug":22,"properties":637,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":640,"statistic":22},[],{"title":638},{"VI":639},"Division of Medical Oncology, Western University and London Health Sciences Centre, London, ON, Canada",[],{"title":642},{"VI":643},"Nicholas Power",{"id":645,"sortIndex":646,"researcher":22,"roles":647,"affiliations":648,"properties":655,"displayName":657,"givenName":22,"familyName":22},"e7c27df0-7fce-43c2-9fa5-dad7d39b70a7",17,[126],[649],{"id":430,"sortIndex":83,"affiliation":650,"properties":22},{"id":430,"createTime":22,"updateTime":22,"relativeEntities":651,"slug":22,"properties":652,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":654,"statistic":22},[],{"title":653},{"VI":435},[],{"title":656},{"VI":657},"Eric Winquist",{"id":659,"sortIndex":660,"researcher":22,"roles":661,"affiliations":662,"properties":669,"displayName":671,"givenName":22,"familyName":22},"63a4d675-d8f1-45fa-bfc5-73e5844f9f89",18,[126],[663],{"id":398,"sortIndex":83,"affiliation":664,"properties":22},{"id":398,"createTime":22,"updateTime":22,"relativeEntities":665,"slug":22,"properties":666,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":668,"statistic":22},[],{"title":667},{"VI":403},[],{"title":670},{"VI":671},"Robert J. Hamilton",{"url":391,"publisher":673,"properties":715},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":674,"slug":10,"properties":675,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":679,"manageAffiliations":684,"indexDatabases":695,"url":81,"thumbnailPath":22,"statistic":710,"gsStatistic":22,"type":22,"analyzePriority":22},[],{"issn":676,"title":677,"country":678},{"VOID":15},{"EN":17},{"VOID":13},[680],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":681,"label":682,"description":683,"parentId":22,"standard":22,"scholarHubFieldId":22},[],{"EN":29},{},[685,690],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":686,"slug":22,"properties":687,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":689,"statistic":22},[],{"title":688},{"EN":37},[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":691,"slug":22,"properties":692,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":694,"statistic":22},[],{"title":693},{"EN":44},[],[696,703],{"id":48,"indexDatabase":697,"url":61,"indexYears":22,"academicFieldIds":702,"indexDatabaseRanking":22},{"id":50,"createTime":22,"updateTime":22,"relativeEntities":698,"label":699,"description":700,"key":57,"publicationTags":701,"standard":22},[],{"EN":53,"VI":53},{"EN":55,"VI":56},[59,60],[63],{"id":65,"indexDatabase":704,"url":76,"indexYears":77,"academicFieldIds":709,"indexDatabaseRanking":80},{"id":67,"createTime":22,"updateTime":22,"relativeEntities":705,"label":706,"description":707,"key":73,"publicationTags":708,"standard":22},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79],{"impactFactor":83,"impactFactorByYear":711,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":712,"totalCitation":83,"totalCitationByYear":713,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":714,"hindexLast5Year":83,"hindex":83},{},{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},{},{},{"pages":716,"volume":718},{"VOID":717},"995-1001",{"VOID":719},"4",42,{"total":720,"publishYear":722,"statisticByYear":723},2018,{"2019":211,"2020":306,"2021":241,"2022":278,"2023":227,"2024":227,"2025":211},"2018-12-01",[59,80],{"id":727,"createTime":728,"updateTime":729,"relativeEntities":730,"slug":731,"properties":732,"entityType":117,"verifyStatus":118,"verifyTime":741,"verifyNote":120,"languages":22,"translateLanguages":22,"viewCount":83,"primaryUrl":742,"fullTextUrl":22,"authors":743,"publicationType":318,"publisherRelationship":793,"citationCount":22,"citationInfo":22,"publishDate":840,"publishYear":368,"citationAnalyzeStatus":21,"lastCitationAnalyze":841,"indexDatabases":842,"openAccess":22,"references":22,"isForceReanalyzing":374},"11c9656a-0a87-4bab-814e-b226134d1373","2023-12-28T21:01:38.997+00:00","2026-07-11T20:50:15.343+00:00",[],"Seek-and-Find-Current-Prospective-Evidence-for-Prostate-specific-Membrane-Antigen-Imaging-to-Detect-Recurrent-Prostate-Cancer",{"title":733,"gsPaper":735,"references":737,"doi":739},{"EN":734},"Seek and Find: Current Prospective Evidence for Prostate-specific Membrane Antigen Imaging to Detect Recurrent Prostate Cancer",{"VOID":736},"[\"9854905296055366854\"]",{"VOID":738},"Parker, 2020, Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 31, 1119, 10.1016\u002Fj.annonc.2020.06.011\nNational Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology for prostate cancer (version 2.2020).\nBriganti, 2015, Natural history of surgically treated high-risk prostate cancer, Urol Oncol Semin Orig Invest, 33\nRoach, 2006, Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference, Int J Radiat Oncol Biol Phys, 65, 965, 10.1016\u002Fj.ijrobp.2006.04.029\nPisansky, 2019, Adjuvant and salvage radiotherapy after prostatectomy: ASTRO\u002FAUA guideline amendment 2018–2019, J Urol, 202, 533, 10.1097\u002FJU.0000000000000295\nScher, 2016, Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3, J Clin Oncol, 34, 1402, 10.1200\u002FJCO.2015.64.2702\nSpratt, 2018, Management of biochemically recurrent prostate cancer: ensuring the right treatment of the right patient at the right time, Am Soc Clin Oncol Educ Book, 38, 355, 10.1200\u002FEDBK_200319\nVargas, 2016, Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng\u002Fml following prostatectomy: how much information can conventional imaging provide?, Urol Oncol Semin Orig Invest, 34\nHricak, 2007, Imaging prostate cancer: a multidisciplinary perspective, Radiology, 243, 28, 10.1148\u002Fradiol.2431030580\nHofman, 2020, Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study, Lancet, 395, 1208, 10.1016\u002FS0140-6736(20)30314-7\nFreedland, 2005, Risk of prostate cancer–specific mortality following biochemical recurrence after radical prostatectomy, JAMA, 294, 433, 10.1001\u002Fjama.294.4.433\nFendler, 2019, PSMA-PET localizes M1 disease in more than half of “non-metastatic” castration-resistant prostate cancer patients, J Nucl Med, 60, 591\nBashir, 2019, Impact of Ga-68-PSMA PET\u002FCT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy, Eur J Nucl Med Mol Imaging, 46, 901, 10.1007\u002Fs00259-018-4249-z\nvon Eyben, 2018, 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\u002Fcomputed tomography for prostate cancer: a systematic review and meta-analysis, Eur Urol Focus, 4, 686, 10.1016\u002Fj.euf.2016.11.002\nPerera, 2020, Eur Urol, 77, 403, 10.1016\u002Fj.eururo.2019.01.049\nEiber, 2018, Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET\u002FCT, J Nucl Med, 59, 469, 10.2967\u002Fjnumed.117.198119\nFendler, 2017, 68Ga-PSMA-11 PET\u002FCT interobserver agreement for prostate cancer assessments: an international multicenter prospective study, J Nucl Med, 58, 1617, 10.2967\u002Fjnumed.117.190827\nToriihara, 2020, Comparison of 3 interpretation criteria for 68Ga-PSMA11 PET based on inter- and intrareader agreement, J Nucl Med, 61, 533, 10.2967\u002Fjnumed.119.232504\nMorris, 2021, Diagnostic performance of (18)F-DCFPyL-PET\u002FCT in men with biochemically recurrent prostate cancer: results from the CONDOR phase 3, multicenter study, Clin Cancer Res, 10.1158\u002F1078-0432.CCR-20-4573\nPienta, 2021, A phase 2\u002F3 prospective multicenter study of the diagnostic accuracy of prostate-specific membrane antigen PET\u002FCT with (18)F-DCFPyL in prostate cancer patients (OSPREY), J Urol, 10.1097\u002FJU.0000000000001698\nAfshar-Oromieh, 2013, PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions, Eur J Nucl Med Mol Imaging, 40, 486, 10.1007\u002Fs00259-012-2298-2\nEiber, 2015, Evaluation of hybrid 68Ga-PSMA ligand PET\u002FCT in 248 patients with biochemical recurrence after radical prostatectomy, J Nucl Med, 56, 668, 10.2967\u002Fjnumed.115.154153\nHope, 2019, Metaanalysis of 68Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology, J Nucl Med, 60, 786, 10.2967\u002Fjnumed.118.219501\nLawhn-Heath, 2019, Single-center prospective evaluation of 68Ga-PSMA-11 PET in biochemical recurrence of prostate cancer, Am J Roentgenol, 213, 266, 10.2214\u002FAJR.18.20699\nFendler, 2019, Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial, JAMA Oncol, 5, 856, 10.1001\u002Fjamaoncol.2019.0096\nHamed, 2019, 68Ga-PSMA PET\u002FCT in patients with rising prostatic-specific antigen after definitive treatment of prostate cancer: detection efficacy and diagnostic accuracy, Acad Radiol, 26, 450, 10.1016\u002Fj.acra.2018.05.020\nAkdemir, 2019, 68 Ga-labelled PSMA ligand HBED-CC PET\u002FCT imaging in patients with recurrent prostate cancer, World J Urol, 37, 813, 10.1007\u002Fs00345-018-2460-y\nDong, 2020, Prospective evaluation of 68Ga-PSMA-11 PET\u002FCT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prostatectomy, and serum PSA level, Med Oncol, 37, 89, 10.1007\u002Fs12032-020-01412-7\nCaroli, 2018, 68Ga-PSMA PET\u002FCT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients, Eur J Nucl Med Mol Imaging, 45, 2035, 10.1007\u002Fs00259-018-4067-3\nBeheshti, 2020, Multi-phasic 68Ga-PSMA PET\u002FCT in detection of early recurrence in prostate cancer patients with PSA\u003C 1 ng\u002Fml: a prospective study of 135 cases, J Nucl Med, 61, 1484, 10.2967\u002Fjnumed.119.238071\nDeandreis, 2020, 68 Ga-PSMA-11 PET\u002FCT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy, Eur J Nucl Med Mol Imaging, 47, 2804, 10.1007\u002Fs00259-020-04809-8\nZacho, 2018, 68Ga-PSMA PET\u002FCT in patients with biochemical recurrence of prostate cancer: a prospective, 2-center study, Clin Nucl Med, 43, 579, 10.1097\u002FRLU.0000000000002169\nFendler, 2021, False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial, Eur J Nucl Med Mol Imaging, 48, 501, 10.1007\u002Fs00259-020-04945-1\nMannweiler, 2009, Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis, Pathol Oncol Res, 15, 167, 10.1007\u002Fs12253-008-9104-2\nEmmett, 2019, Rapid modulation of PSMA expression by androgen deprivation: serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade, J Nucl Med, 60, 950, 10.2967\u002Fjnumed.118.223099\nRousseau, 2019, Preliminary results of a 68Ga‐PSMA PET\u002FCT prospective study in prostate cancer patients with occult recurrence: diagnostic performance and impact on therapeutic decision‐making, Prostate, 79, 1514, 10.1002\u002Fpros.23869\nMena, 2020, 18F-DCFPyL PET\u002FCT imaging in patients with biochemically recurrent prostate cancer after primary local therapy, J Nucl Med, 61, 881, 10.2967\u002Fjnumed.119.234799\nAbufaraj, 2019, Prospective evaluation of the performance of [(68)Ga]Ga-PSMA-11 PET\u002FCT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy, Eur J Nucl Med Mol Imaging, 46, 2169, 10.1007\u002Fs00259-019-04361-0\nvan Leeuwen, 2016, 68Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment, BJU Int, 117, 732, 10.1111\u002Fbju.13397\nWerner, 2020, (18)F-labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging, Theranostics, 10, 1, 10.7150\u002Fthno.37894\nRowe, 2016, PSMA-based [18 F] DCFPyL PET\u002FCT is superior to conventional imaging for lesion detection in patients with metastatic prostate cancer, Mol Imaging Biol, 18, 411, 10.1007\u002Fs11307-016-0957-6\nDietlein, 2017, PSA-stratified performance of 18F-and 68Ga-PSMA PET in patients with biochemical recurrence of prostate cancer, J Nucl Med, 58, 947, 10.2967\u002Fjnumed.116.185538\nSong, 2020, Prospective evaluation in an academic center of 18F-DCFPyL PET\u002FCT in biochemically recurrent prostate cancer: a focus on localizing disease and changes in management, J Nucl Med, 61, 546, 10.2967\u002Fjnumed.119.231654\nRousseau, 2019, A prospective study on (18)F-DCFPyL PSMA PET\u002FCT imaging in biochemical recurrence of prostate cancer, J Nucl Med, 60, 1587, 10.2967\u002Fjnumed.119.226381\nGiesel, 2019, Detection efficacy of 18F-PSMA-1007 PET\u002FCT in 251 patients with biochemical recurrence of prostate cancer after radical prostatectomy, J Nucl Med, 60, 362, 10.2967\u002Fjnumed.118.212233\nWitkowska-Patena, 2020, Diagnostic performance of 18F-PSMA-1007 PET\u002FCT in biochemically relapsed patients with prostate cancer with PSA levels≤ 2.0 ng\u002Fml, Prostate Cancer Prostatic Dis, 23, 343, 10.1038\u002Fs41391-019-0194-6\nRoach, 2018, The impact of 68Ga-PSMA PET\u002FCT on management intent in prostate cancer: results of an Australian prospective multicenter study, J Nucl Med, 59, 82, 10.2967\u002Fjnumed.117.197160\nEmmett, 2020, 3-Year freedom from progression after 68Ga-PSMA PET\u002FCT–triaged management in men with biochemical recurrence after radical prostatectomy: results of a prospective multicenter trial, J Nucl Med, 61, 866, 10.2967\u002Fjnumed.119.235028\nCalais, 2018, Impact of 68Ga-PSMA-11 PET\u002FCT on the management of prostate cancer patients with biochemical recurrence, J Nucl Med, 59, 434, 10.2967\u002Fjnumed.117.202945\nHope, 2017, Impact of 68Ga-PSMA-11 PET on management in patients with biochemically recurrent prostate cancer, J Nucl Med, 58, 1956, 10.2967\u002Fjnumed.117.192476\nBianchi, 2019, How does 68Ga-prostate-specific membrane antigen positron emission tomography\u002Fcomputed tomography impact the management of patients with prostate cancer recurrence after surgery?, Int J Urol, 26, 804, 10.1111\u002Fiju.14012\nLiu, 2020, A prospective study of 18F-DCFPyL PSMA PET\u002FCT restaging in recurrent prostate cancer following primary external beam radiotherapy or brachytherapy, Int J Radiat Oncol Biol Phys, 106, 546, 10.1016\u002Fj.ijrobp.2019.11.001\nPhillips, 2020, Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial, JAMA Oncol, 6, 650, 10.1001\u002Fjamaoncol.2020.0147\nOst, 2020, Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): five-year results of a randomized phase II trial, J Clin Oncol, 38, 10, 10.1200\u002FJCO.2020.38.6_suppl.10\nGillessen, 2020, Management of patients with advanced prostate cancer: report of the Advanced Prostate Cancer Consensus Conference 2019, Eur Urol, 77, 508, 10.1016\u002Fj.eururo.2020.01.012\nKneebone, 2018, Stereotactic body radiotherapy for oligometastatic prostate cancer detected via prostate-specific membrane antigen positron emission tomography, Eur Urol Oncol, 1, 531, 10.1016\u002Fj.euo.2018.04.017\nStefan, 2021, Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer, Eur J Nucl Med Mol Imaging, 48, 143, 10.1007\u002Fs00259-020-04777-z\nSawicki, 2019, Prospective comparison of whole-body MRI and 68 Ga-PSMA PET\u002FCT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy, Eur J Nucl Med Mol Imaging, 46, 1542, 10.1007\u002Fs00259-019-04308-5\nICECaP Working Group, 2015, The development of intermediate clinical endpoints in cancer of the prostate (ICECaP), J Natl Cancer Inst, 107, djv261, 10.1093\u002Fjnci\u002Fdjv261\nCalais, 2019, Randomized prospective phase III trial of (68)Ga-PSMA-11 PET\u002FCT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT], BMC Cancer, 19, 18, 10.1186\u002Fs12885-018-5200-1\nJoshi, 2020, The clinical efficacy of PSMA PET\u002FMRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trial, Clin Exp Metastasis, 37, 551, 10.1007\u002Fs10585-020-10043-1\nMcCarthy, 2019, A multicenter prospective clinical trial of 68Gallium PSMA HBED-CC PET-CT restaging in biochemically relapsed prostate carcinoma: oligometastatic rate and distribution compared with standard imaging, Int J Radiat Oncol Biol Phys, 104, 801, 10.1016\u002Fj.ijrobp.2019.03.014\nEmmett, 2019, J Nucl Med, 60, 794, 10.2967\u002Fjnumed.118.220103\nMena, 2018, Clinical impact of PSMA-based 18 F–DCFBC PET\u002FCT imaging in patients with biochemically recurrent prostate cancer after primary local therapy, Eur J Nucl Med Mol Imaging, 45, 4, 10.1007\u002Fs00259-017-3818-x\nRowe, 2020, Prospective evaluation of PSMA-targeted 18F-DCFPyL PET\u002FCT in men with biochemical failure after radical prostatectomy for prostate cancer, J Nucl Med, 61, 58, 10.2967\u002Fjnumed.119.226514",{"VOID":740},"10.1016\u002Fj.euf.2021.03.012","2024-06-25T18:03:43.935+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS2405456921000699",[744,759,776],{"id":745,"sortIndex":83,"researcher":22,"roles":746,"affiliations":747,"properties":756,"displayName":758,"givenName":22,"familyName":22},"87d69c91-a809-483a-b571-a075b883be29",[126],[748],{"id":749,"sortIndex":83,"affiliation":750,"properties":22},"6c8dc512-2862-49e4-ab6c-d21811f36a06",{"id":749,"createTime":22,"updateTime":22,"relativeEntities":751,"slug":22,"properties":752,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":755,"statistic":22},[],{"title":753},{"VI":754},"Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA",[],{"title":757},{"VI":758},"Niamh M. Keegan",{"id":760,"sortIndex":141,"researcher":22,"roles":761,"affiliations":762,"properties":771,"displayName":773,"givenName":22,"familyName":22},"ecc854dc-942c-4990-8489-6d5056b52763",[126],[763],{"id":764,"sortIndex":83,"affiliation":765,"properties":22},"7471dc38-d366-4a2f-8f7b-0580e418000a",{"id":764,"createTime":22,"updateTime":22,"relativeEntities":766,"slug":22,"properties":767,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":770,"statistic":22},[],{"title":768},{"VI":769},"Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA",[],{"title":772,"gsAuthor":774},{"VI":773},"Lisa Bodei",{"VOID":775},"[\"tlDNwFAAAAAJ\"]",{"id":777,"sortIndex":165,"researcher":22,"roles":778,"affiliations":779,"properties":788,"displayName":790,"givenName":22,"familyName":22},"b1ee551c-1d4d-4cf4-8ed5-ecb52623d417",[126],[780],{"id":781,"sortIndex":83,"affiliation":782,"properties":22},"7182d6d9-969c-4437-bdd4-c03aba3af92a",{"id":781,"createTime":22,"updateTime":22,"relativeEntities":783,"slug":22,"properties":784,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":787,"statistic":22},[],{"title":785},{"VI":786},"Genitourinary Medical Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY, USA",[],{"title":789,"gsAuthor":791},{"VI":790},"Michael J. Morris",{"VOID":792},"[\"UgO0jr4AAAAJ\"]",{"url":742,"publisher":794,"properties":836},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":795,"slug":10,"properties":796,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":800,"manageAffiliations":805,"indexDatabases":816,"url":81,"thumbnailPath":22,"statistic":831,"gsStatistic":22,"type":22,"analyzePriority":22},[],{"issn":797,"title":798,"country":799},{"VOID":15},{"EN":17},{"VOID":13},[801],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":802,"label":803,"description":804,"parentId":22,"standard":22,"scholarHubFieldId":22},[],{"EN":29},{},[806,811],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":807,"slug":22,"properties":808,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":810,"statistic":22},[],{"title":809},{"EN":37},[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":812,"slug":22,"properties":813,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":815,"statistic":22},[],{"title":814},{"EN":44},[],[817,824],{"id":48,"indexDatabase":818,"url":61,"indexYears":22,"academicFieldIds":823,"indexDatabaseRanking":22},{"id":50,"createTime":22,"updateTime":22,"relativeEntities":819,"label":820,"description":821,"key":57,"publicationTags":822,"standard":22},[],{"EN":53,"VI":53},{"EN":55,"VI":56},[59,60],[63],{"id":65,"indexDatabase":825,"url":76,"indexYears":77,"academicFieldIds":830,"indexDatabaseRanking":80},{"id":67,"createTime":22,"updateTime":22,"relativeEntities":826,"label":827,"description":828,"key":73,"publicationTags":829,"standard":22},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79],{"impactFactor":83,"impactFactorByYear":832,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":833,"totalCitation":83,"totalCitationByYear":834,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":835,"hindexLast5Year":83,"hindex":83},{},{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},{},{},{"pages":837,"volume":839},{"VOID":838},"267-278",{"VOID":366},"2021-03-01","2026-07-11T20:50:15.342+00:00",[59,80],{"id":844,"createTime":845,"updateTime":846,"relativeEntities":847,"slug":848,"properties":849,"entityType":117,"verifyStatus":118,"verifyTime":858,"verifyNote":120,"languages":22,"translateLanguages":22,"viewCount":141,"primaryUrl":859,"fullTextUrl":22,"authors":860,"publicationType":318,"publisherRelationship":1111,"citationCount":22,"citationInfo":22,"publishDate":1159,"publishYear":1160,"citationAnalyzeStatus":1161,"lastCitationAnalyze":1162,"indexDatabases":1163,"openAccess":22,"references":22,"isForceReanalyzing":374},"8fdfca14-14dc-4917-8137-10fe858f8038","2024-01-17T05:14:38.766+00:00","2026-07-08T06:04:00.751+00:00",[],"Reducing-the-Risk-of-Postoperative-Complications-After-Robot-assisted-Radical-Prostatectomy-in-Prostate-Cancer-Patients-Results-of-an-Audit-and-Feedback-Intervention-Following-the-Implementation-of-Prospective-Data-Collection",{"title":850,"gsPaper":852,"references":854,"doi":856},{"EN":851},"Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection",{"VOID":853},"[]",{"VOID":855},"Novara, 2012, Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy, Eur Urol, 62, 431, 10.1016\u002Fj.eururo.2012.05.044\nNovara, 2010, Prospective evaluation with standardised criteria for postoperative complications after robotic-assisted laparoscopic radical prostatectomy, Eur Urol, 57, 363, 10.1016\u002Fj.eururo.2009.11.032\nCheng, 2014, Standardized report for early complications of radical prostatectomy, J Chin Med Assoc, 77, 234, 10.1016\u002Fj.jcma.2014.02.008\nNyberg, 2018, Functional and oncologic outcomes between open and robotic radical prostatectomy at 24-month follow-up in the Swedish LAPPRO trial, Eur Urol Oncol, 1, 353, 10.1016\u002Fj.euo.2018.04.012\nGandaglia, 2018, The impact of implementation of the European Association of Urology Guidelines Panel recommendations on reporting and grading complications on perioperative outcomes after robot-assisted radical prostatectomy, Eur Urol, 74, 4, 10.1016\u002Fj.eururo.2018.02.025\nRosiello, 2021, The impact of previous prostate surgery on surgical outcomes for patients treated with robot-assisted radical cystectomy for bladder cancer, Eur Urol, 10.1016\u002Fj.eururo.2021.02.029\nTewari, 2012, Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy, Eur Urol, 62, 1, 10.1016\u002Fj.eururo.2012.02.029\nJamtvedt, 2003, Audit and feedback: effects on professional practice and health care outcomes, Cochrane Database Syst Rev, 2003, 10.1002\u002F14651858.CD000259\nGratzke, 2016, Early catheter removal after robot-assisted radical prostatectomy: surgical technique and outcomes for the Aalst technique (ECaRemA Study), Eur Urol, 69, 917, 10.1016\u002Fj.eururo.2015.09.052\nMazzone E, Dell’Oglio P, Rosiello G, et al. Technical refinements in superextended robot-assisted radical prostatectomy for locally advanced prostate cancer patients at multiparametric magnetic resonance imaging. Eur Urol. In press. https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.eururo.2020.09.009.\nMottrie, 2007, Robot-assisted laparoscopic radical prostatectomy: oncologic and functional results of 184 cases, Eur Urol, 52, 746, 10.1016\u002Fj.eururo.2007.02.029\nRocco, 2007, Early continence recovery after open radical prostatectomy with restoration of the posterior aspect of the rhabdosphincter, Eur Urol, 52, 376, 10.1016\u002Fj.eururo.2007.01.109\nVan Velthoven, 2003, Technique for laparoscopic running urethrovesical anastomosis: the single knot method, Urology, 61, 699, 10.1016\u002FS0090-4295(02)02543-8\nClavien, 2009, The Clavien-Dindo classification of surgical complications: five-year experience, Ann Surg, 250, 187, 10.1097\u002FSLA.0b013e3181b13ca2\nMitropoulos, 2012, Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU Guidelines Panel assessment and recommendations, Eur Urol, 61, 341, 10.1016\u002Fj.eururo.2011.10.033\nMacLennan, 2018, Knowledge transfer and guidelines implementation in genitourinary cancers, Eur Urol Oncol, 1, 426, 10.1016\u002Fj.euo.2018.06.017\nLarcher, 2019, The learning curve for robot-assisted partial nephrectomy: impact of surgical experience on perioperative outcomes, Eur Urol, 75, 253, 10.1016\u002Fj.eururo.2018.08.042\nDell’Oglio, 2019, The effect of surgical experience on perioperative and oncological outcomes after robot-assisted radical cystectomy with intracorporeal urinary diversion: evidence from a high-volume center, Eur Urol Suppl, 18\nPeard, 2019, Examining and understanding value: the impact of preoperative characteristics, intraoperative variables, and postoperative complications on cost of robot-assisted laparoscopic radical prostatectomy, J Endourol, 33, 541, 10.1089\u002Fend.2019.0066\nDavenport, 2005, Preoperative risk factors and surgical complexity are more predictive of costs than postoperative complications: a case study using the National Surgical Quality Improvement Program (NSQIP) database, Ann Surg, 242, 463, 10.1097\u002F01.sla.0000183348.15117.ab\nShah, 2019, Incidence, cost, and risk factors for readmission after coronary artery bypass grafting, Ann Thorac Surg, 107, 1782, 10.1016\u002Fj.athoracsur.2018.10.077\nWang, 2018, Cost and cost-effectiveness studies in urologic oncology using large administrative databases, Urol Oncol, 36, 213, 10.1016\u002Fj.urolonc.2018.01.015\nFriberg AS, Dalton SO, Larsen SB, et al. Risk of depression after radical prostatectomy—a nationwide registry-based study. Eur Urol Oncol. In press. https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.euo.2019.06.020.",{"VOID":857},"10.1016\u002Fj.euf.2021.03.026","2024-06-24T12:24:02.108+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS240545692100105X",[861,894,907,920,933,946,959,972,985,998,1011,1024,1037,1050,1065,1085,1098],{"id":862,"sortIndex":83,"researcher":22,"roles":863,"affiliations":864,"properties":891,"displayName":893,"givenName":22,"familyName":22},"323d3b14-e5c1-4c3d-84e1-cb2d11b99c4a",[126],[865,873,882],{"id":866,"sortIndex":83,"affiliation":867,"properties":22},"ba4f4d33-5774-4230-b09b-d30df42236d9",{"id":866,"createTime":22,"updateTime":22,"relativeEntities":868,"slug":22,"properties":869,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":872,"statistic":22},[],{"title":870},{"VI":871},"Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy",[],{"id":874,"sortIndex":141,"affiliation":875,"properties":881},"202a4d0b-cb5e-488f-96e8-aa0ab5b42016",{"id":874,"createTime":22,"updateTime":22,"relativeEntities":876,"slug":22,"properties":877,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":880,"statistic":22},[],{"title":878},{"VI":879},"Department of Urology, Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium",[],{},{"id":883,"sortIndex":165,"affiliation":884,"properties":890},"18f85c19-a52c-43ac-8f60-dfcf10109254",{"id":883,"createTime":22,"updateTime":22,"relativeEntities":885,"slug":22,"properties":886,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":889,"statistic":22},[],{"title":887},{"VI":888},"ORSI Academy, Melle, Belgium",[],{},{"title":892},{"VI":893},"Giuseppe Rosiello",{"id":895,"sortIndex":141,"researcher":22,"roles":896,"affiliations":897,"properties":904,"displayName":906,"givenName":22,"familyName":22},"6a89ad67-7240-419b-85ee-acdf1858eb1a",[126],[898],{"id":866,"sortIndex":83,"affiliation":899,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":900,"slug":22,"properties":901,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":903,"statistic":22},[],{"title":902},{"VI":871},[],{"title":905},{"VI":906},"Giorgio Gandaglia",{"id":908,"sortIndex":165,"researcher":22,"roles":909,"affiliations":910,"properties":917,"displayName":919,"givenName":22,"familyName":22},"051c1650-d792-483c-bfd0-53fdbabf2dc6",[126],[911],{"id":866,"sortIndex":83,"affiliation":912,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":913,"slug":22,"properties":914,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":916,"statistic":22},[],{"title":915},{"VI":871},[],{"title":918},{"VI":919},"Simone Scuderi",{"id":921,"sortIndex":197,"researcher":22,"roles":922,"affiliations":923,"properties":930,"displayName":932,"givenName":22,"familyName":22},"935e4931-cb13-4bbb-b7cf-6a6c5aa2bda9",[126],[924],{"id":866,"sortIndex":83,"affiliation":925,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":926,"slug":22,"properties":927,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":929,"statistic":22},[],{"title":928},{"VI":871},[],{"title":931},{"VI":932},"Francesco Barletta",{"id":934,"sortIndex":211,"researcher":22,"roles":935,"affiliations":936,"properties":943,"displayName":945,"givenName":22,"familyName":22},"66bb09b2-b6b1-4077-a7d9-4fcfd5ef3c07",[126],[937],{"id":866,"sortIndex":83,"affiliation":938,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":939,"slug":22,"properties":940,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":942,"statistic":22},[],{"title":941},{"VI":871},[],{"title":944},{"VI":945},"Nicola Fossati",{"id":947,"sortIndex":227,"researcher":22,"roles":948,"affiliations":949,"properties":956,"displayName":958,"givenName":22,"familyName":22},"798d9ded-6631-4d96-8242-024dfa180baf",[126],[950],{"id":866,"sortIndex":83,"affiliation":951,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":952,"slug":22,"properties":953,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":955,"statistic":22},[],{"title":954},{"VI":871},[],{"title":957},{"VI":958},"Armando Stabile",{"id":960,"sortIndex":241,"researcher":22,"roles":961,"affiliations":962,"properties":969,"displayName":971,"givenName":22,"familyName":22},"f72733c5-628b-45bc-a7e7-2465998cbfc5",[126],[963],{"id":866,"sortIndex":83,"affiliation":964,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":965,"slug":22,"properties":966,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":968,"statistic":22},[],{"title":967},{"VI":871},[],{"title":970},{"VI":971},"Andrea Gallina",{"id":973,"sortIndex":264,"researcher":22,"roles":974,"affiliations":975,"properties":982,"displayName":984,"givenName":22,"familyName":22},"e9686bf6-4ed7-46cb-8719-fd5165dbd279",[126],[976],{"id":866,"sortIndex":83,"affiliation":977,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":978,"slug":22,"properties":979,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":981,"statistic":22},[],{"title":980},{"VI":871},[],{"title":983},{"VI":984},"Elio Mazzone",{"id":986,"sortIndex":278,"researcher":22,"roles":987,"affiliations":988,"properties":995,"displayName":997,"givenName":22,"familyName":22},"78de87fb-21dd-4f4a-a3f0-a13b72069f85",[126],[989],{"id":866,"sortIndex":83,"affiliation":990,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":991,"slug":22,"properties":992,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":994,"statistic":22},[],{"title":993},{"VI":871},[],{"title":996},{"VI":997},"Luca Maria Vitale",{"id":999,"sortIndex":292,"researcher":22,"roles":1000,"affiliations":1001,"properties":1008,"displayName":1010,"givenName":22,"familyName":22},"688f8e30-ca64-4a4c-bb45-0107d48c43fb",[126],[1002],{"id":866,"sortIndex":83,"affiliation":1003,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":1004,"slug":22,"properties":1005,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1007,"statistic":22},[],{"title":1006},{"VI":871},[],{"title":1009},{"VI":1010},"Antony Pellegrino",{"id":1012,"sortIndex":306,"researcher":22,"roles":1013,"affiliations":1014,"properties":1021,"displayName":1023,"givenName":22,"familyName":22},"fe78dedf-a03c-4f05-a439-e33e255fb674",[126],[1015],{"id":866,"sortIndex":83,"affiliation":1016,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":1017,"slug":22,"properties":1018,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1020,"statistic":22},[],{"title":1019},{"VI":871},[],{"title":1022},{"VI":1023},"Carlo Bravi",{"id":1025,"sortIndex":556,"researcher":22,"roles":1026,"affiliations":1027,"properties":1034,"displayName":1036,"givenName":22,"familyName":22},"6983642d-312a-407b-93ac-62c8bea5c291",[126],[1028],{"id":866,"sortIndex":83,"affiliation":1029,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":1030,"slug":22,"properties":1031,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1033,"statistic":22},[],{"title":1032},{"VI":871},[],{"title":1035},{"VI":1036},"Alberto Martini",{"id":1038,"sortIndex":572,"researcher":22,"roles":1039,"affiliations":1040,"properties":1047,"displayName":1049,"givenName":22,"familyName":22},"42c924fb-07d7-4bf7-9e32-fa9da913b0f5",[126],[1041],{"id":866,"sortIndex":83,"affiliation":1042,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":1043,"slug":22,"properties":1044,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1046,"statistic":22},[],{"title":1045},{"VI":871},[],{"title":1048},{"VI":1049},"Vito Cucchiara",{"id":1051,"sortIndex":586,"researcher":22,"roles":1052,"affiliations":1053,"properties":1062,"displayName":1064,"givenName":22,"familyName":22},"344c2e24-df7e-4389-a65d-665c8598e267",[126],[1054],{"id":1055,"sortIndex":83,"affiliation":1056,"properties":22},"869cdb2d-681c-4ac4-bf94-49515c94eafb",{"id":1055,"createTime":22,"updateTime":22,"relativeEntities":1057,"slug":22,"properties":1058,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1061,"statistic":22},[],{"title":1059},{"VI":1060},"Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada",[],{"title":1063},{"VI":1064},"Pierre I. Karakiewicz",{"id":1066,"sortIndex":600,"researcher":22,"roles":1067,"affiliations":1068,"properties":1082,"displayName":1084,"givenName":22,"familyName":22},"e920d536-e44a-4868-af14-76e5cd098d87",[126],[1069,1075],{"id":874,"sortIndex":83,"affiliation":1070,"properties":22},{"id":874,"createTime":22,"updateTime":22,"relativeEntities":1071,"slug":22,"properties":1072,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1074,"statistic":22},[],{"title":1073},{"VI":879},[],{"id":883,"sortIndex":141,"affiliation":1076,"properties":1081},{"id":883,"createTime":22,"updateTime":22,"relativeEntities":1077,"slug":22,"properties":1078,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1080,"statistic":22},[],{"title":1079},{"VI":888},[],{},{"title":1083},{"VI":1084},"Alexandre Mottrie",{"id":1086,"sortIndex":616,"researcher":22,"roles":1087,"affiliations":1088,"properties":1095,"displayName":1097,"givenName":22,"familyName":22},"9e44aafd-6eee-4158-ab27-78c5f06eb044",[126],[1089],{"id":866,"sortIndex":83,"affiliation":1090,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":1091,"slug":22,"properties":1092,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1094,"statistic":22},[],{"title":1093},{"VI":871},[],{"title":1096},{"VI":1097},"Alberto Briganti",{"id":1099,"sortIndex":630,"researcher":22,"roles":1100,"affiliations":1101,"properties":1108,"displayName":1110,"givenName":22,"familyName":22},"4be1816c-f073-407d-80a7-b4f0d3f5f130",[126],[1102],{"id":866,"sortIndex":83,"affiliation":1103,"properties":22},{"id":866,"createTime":22,"updateTime":22,"relativeEntities":1104,"slug":22,"properties":1105,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1107,"statistic":22},[],{"title":1106},{"VI":871},[],{"title":1109},{"VI":1110},"Francesco Montorsi",{"url":859,"publisher":1112,"properties":1154},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1113,"slug":10,"properties":1114,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":1118,"manageAffiliations":1123,"indexDatabases":1134,"url":81,"thumbnailPath":22,"statistic":1149,"gsStatistic":22,"type":22,"analyzePriority":22},[],{"issn":1115,"title":1116,"country":1117},{"VOID":15},{"EN":17},{"VOID":13},[1119],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":1120,"label":1121,"description":1122,"parentId":22,"standard":22,"scholarHubFieldId":22},[],{"EN":29},{},[1124,1129],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":1125,"slug":22,"properties":1126,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1128,"statistic":22},[],{"title":1127},{"EN":37},[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":1130,"slug":22,"properties":1131,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1133,"statistic":22},[],{"title":1132},{"EN":44},[],[1135,1142],{"id":48,"indexDatabase":1136,"url":61,"indexYears":22,"academicFieldIds":1141,"indexDatabaseRanking":22},{"id":50,"createTime":22,"updateTime":22,"relativeEntities":1137,"label":1138,"description":1139,"key":57,"publicationTags":1140,"standard":22},[],{"EN":53,"VI":53},{"EN":55,"VI":56},[59,60],[63],{"id":65,"indexDatabase":1143,"url":76,"indexYears":77,"academicFieldIds":1148,"indexDatabaseRanking":80},{"id":67,"createTime":22,"updateTime":22,"relativeEntities":1144,"label":1145,"description":1146,"key":73,"publicationTags":1147,"standard":22},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79],{"impactFactor":83,"impactFactorByYear":1150,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":1151,"totalCitation":83,"totalCitationByYear":1152,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":1153,"hindexLast5Year":83,"hindex":83},{},{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},{},{},{"pages":1155,"volume":1157},{"VOID":1156},"431-437",{"VOID":1158},"8","2022-03-01",2022,"ERROR_IN_GET_PLATFORM_ID","2026-07-08T06:04:00.750+00:00",[59,80],{"id":1165,"createTime":1166,"updateTime":1167,"relativeEntities":1168,"slug":1169,"properties":1170,"entityType":117,"verifyStatus":118,"verifyTime":1179,"verifyNote":120,"languages":22,"translateLanguages":22,"viewCount":141,"primaryUrl":1180,"fullTextUrl":22,"authors":1181,"publicationType":318,"publisherRelationship":1446,"citationCount":83,"citationInfo":1494,"publishDate":1497,"publishYear":1495,"citationAnalyzeStatus":21,"lastCitationAnalyze":1498,"indexDatabases":1499,"openAccess":22,"references":22,"isForceReanalyzing":374},"a3e7dafc-942c-4d2f-8084-80850832b9c6","2024-01-16T23:35:14.163+00:00","2026-04-11T12:11:27.205+00:00",[],"The-Association-of-Uromodulin-Genotype-with-Renal-Cancer-Aggressiveness",{"title":1171,"gsPaper":1173,"references":1175,"doi":1177},{"EN":1172},"The Association of Uromodulin Genotype with Renal Cancer Aggressiveness",{"VOID":1174},"[\"8251466572213267985\"]",{"VOID":1176},"Rampoldi, 2011, The rediscovery of uromodulin (Tamm–Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease, Kidney Int, 80, 338, 10.1038\u002Fki.2011.134\nKöttgen, 2009, Multiple loci associated with indices of renal function and chronic kidney disease, Nat Genet, 41, 712, 10.1038\u002Fng.377\nPadmanabhan, 2010, Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension, PLoS Genet, 6, e1001177, 10.1371\u002Fjournal.pgen.1001177\nTrudu, 2013, Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression, Nat Med, 19, 1655, 10.1038\u002Fnm.3384\nOlden, 2014, Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis, J Am Soc Nephrol, 25, 1869, 10.1681\u002FASN.2013070781\nEikrem, 2016, Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing, Scand J Urol, 50, 452, 10.1080\u002F21681805.2016.1238007\nSandim, 2016, Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma, Urol Oncol, 34, 10.1016\u002Fj.urolonc.2015.07.016\nGhirotto, 2016, The uromodulin gene locus shows evidence of pathogen adaptation through human evolution, J Am Soc Nephrol, 27, 2983, 10.1681\u002FASN.2015070830\nBrunati, 2015, The serine protease hepsin mediates urinary secretion and polymerisation of Zona Pellucida domain protein uromodulin, ELife, 17, e08887, 10.7554\u002FeLife.08887\nDawnay, 1980, The development of a radioimmunoassay for Tamm–Horsfall glycoprotein in serum, Biochem J, 185, 679, 10.1042\u002Fbj1850679\nEl-Achkar, 2015, Tubular cross talk in acute kidney injury: a story of sense and sensibility, Am J Physiol Renal Physiol, 308, F1317, 10.1152\u002Fajprenal.00030.2015\nGarimella, 2017, Association of preoperative urinary uromodulin with AKI after cardiac surgery, Clin J Am Soc Nephrol, 12, 10, 10.2215\u002FCJN.02520316\nEl-Achkar, 2012, Uromodulin in kidney injury: an instigator, bystander, or protector?, Am J Kidney Dis, 59, 452, 10.1053\u002Fj.ajkd.2011.10.054",{"VOID":1178},"10.1016\u002Fj.euf.2017.04.009","2024-05-05T04:53:10.602+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS2405456917301153",[1182,1206,1227,1240,1261,1281,1294,1307,1320,1333,1353,1373,1392,1412,1427],{"id":1183,"sortIndex":83,"researcher":22,"roles":1184,"affiliations":1185,"properties":1203,"displayName":1205,"givenName":22,"familyName":22},"fa007a61-6397-4180-94e6-253cdd523b6c",[126],[1186,1194],{"id":1187,"sortIndex":83,"affiliation":1188,"properties":22},"253a9b79-9c37-44d0-8d72-840c2d1b5851",{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1189,"slug":22,"properties":1190,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1193,"statistic":22},[],{"title":1191},{"VI":1192},"URI - Urological Research Institute, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy",[],{"id":1195,"sortIndex":141,"affiliation":1196,"properties":1202},"06338333-baa3-4451-ac46-b4967de0f9b9",{"id":1195,"createTime":22,"updateTime":22,"relativeEntities":1197,"slug":22,"properties":1198,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1201,"statistic":22},[],{"title":1199},{"VI":1200},"Unit of Urology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy",[],{},{"title":1204},{"VI":1205},"Francesco Trevisani",{"id":1207,"sortIndex":141,"researcher":22,"roles":1208,"affiliations":1209,"properties":1222,"displayName":1224,"givenName":22,"familyName":22},"e0682a3b-7d14-4a3d-9c96-a9467fce0dd9",[126],[1210,1216],{"id":1187,"sortIndex":83,"affiliation":1211,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1212,"slug":22,"properties":1213,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1215,"statistic":22},[],{"title":1214},{"VI":1192},[],{"id":1195,"sortIndex":141,"affiliation":1217,"properties":22},{"id":1195,"createTime":22,"updateTime":22,"relativeEntities":1218,"slug":22,"properties":1219,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1221,"statistic":22},[],{"title":1220},{"VI":1200},[],{"title":1223,"gsAuthor":1225},{"VI":1224},"Alessandro Larcher",{"VOID":1226},"[\"eLZel5EAAAAJ\"]",{"id":1228,"sortIndex":165,"researcher":22,"roles":1229,"affiliations":1230,"properties":1237,"displayName":1239,"givenName":22,"familyName":22},"e667953f-6469-4798-aaa6-284ad565be57",[126],[1231],{"id":1187,"sortIndex":83,"affiliation":1232,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1233,"slug":22,"properties":1234,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1236,"statistic":22},[],{"title":1235},{"VI":1192},[],{"title":1238},{"VI":1239},"Alessandra Cinque",{"id":1241,"sortIndex":197,"researcher":22,"roles":1242,"affiliations":1243,"properties":1256,"displayName":1258,"givenName":22,"familyName":22},"a44f0e04-1eca-4c74-9fdb-4228a58abf06",[126],[1244,1250],{"id":1187,"sortIndex":83,"affiliation":1245,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1246,"slug":22,"properties":1247,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1249,"statistic":22},[],{"title":1248},{"VI":1192},[],{"id":1195,"sortIndex":141,"affiliation":1251,"properties":22},{"id":1195,"createTime":22,"updateTime":22,"relativeEntities":1252,"slug":22,"properties":1253,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1255,"statistic":22},[],{"title":1254},{"VI":1200},[],{"title":1257,"gsAuthor":1259},{"VI":1258},"Umberto Capitanio",{"VOID":1260},"[\"Ij8wmcsAAAAJ\"]",{"id":1262,"sortIndex":211,"researcher":22,"roles":1263,"affiliations":1264,"properties":1278,"displayName":1280,"givenName":22,"familyName":22},"204d7737-21ec-474c-aef6-f205e4f91285",[126],[1265,1271],{"id":1187,"sortIndex":83,"affiliation":1266,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1267,"slug":22,"properties":1268,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1270,"statistic":22},[],{"title":1269},{"VI":1192},[],{"id":1195,"sortIndex":141,"affiliation":1272,"properties":1277},{"id":1195,"createTime":22,"updateTime":22,"relativeEntities":1273,"slug":22,"properties":1274,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1276,"statistic":22},[],{"title":1275},{"VI":1200},[],{},{"title":1279},{"VI":1280},"Francesco Ripa",{"id":1282,"sortIndex":227,"researcher":22,"roles":1283,"affiliations":1284,"properties":1291,"displayName":1293,"givenName":22,"familyName":22},"2255aa02-5080-43d6-b816-6dc3ffc86e97",[126],[1285],{"id":1187,"sortIndex":83,"affiliation":1286,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1287,"slug":22,"properties":1288,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1290,"statistic":22},[],{"title":1289},{"VI":1192},[],{"title":1292},{"VI":1293},"Riccardo Vago",{"id":1295,"sortIndex":241,"researcher":22,"roles":1296,"affiliations":1297,"properties":1304,"displayName":1306,"givenName":22,"familyName":22},"6f1e089f-58f7-4467-840a-9bd90de13da4",[126],[1298],{"id":1187,"sortIndex":83,"affiliation":1299,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1300,"slug":22,"properties":1301,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1303,"statistic":22},[],{"title":1302},{"VI":1192},[],{"title":1305},{"VI":1306},"Arianna Bettiga",{"id":1308,"sortIndex":264,"researcher":22,"roles":1309,"affiliations":1310,"properties":1317,"displayName":1319,"givenName":22,"familyName":22},"f4289451-89ed-41ab-9430-668e35c851b4",[126],[1311],{"id":1187,"sortIndex":83,"affiliation":1312,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1313,"slug":22,"properties":1314,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1316,"statistic":22},[],{"title":1315},{"VI":1192},[],{"title":1318},{"VI":1319},"Fabio Benigni",{"id":1321,"sortIndex":278,"researcher":22,"roles":1322,"affiliations":1323,"properties":1330,"displayName":1332,"givenName":22,"familyName":22},"1c670386-7f93-44d1-84a2-dcfb06a3af08",[126],[1324],{"id":1187,"sortIndex":83,"affiliation":1325,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1326,"slug":22,"properties":1327,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1329,"statistic":22},[],{"title":1328},{"VI":1192},[],{"title":1331},{"VI":1332},"Cristina Carenzi",{"id":1334,"sortIndex":292,"researcher":22,"roles":1335,"affiliations":1336,"properties":1350,"displayName":1352,"givenName":22,"familyName":22},"a4425a40-61ec-407d-9310-fba36f07161d",[126],[1337,1343],{"id":1187,"sortIndex":83,"affiliation":1338,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1339,"slug":22,"properties":1340,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1342,"statistic":22},[],{"title":1341},{"VI":1192},[],{"id":1195,"sortIndex":141,"affiliation":1344,"properties":1349},{"id":1195,"createTime":22,"updateTime":22,"relativeEntities":1345,"slug":22,"properties":1346,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1348,"statistic":22},[],{"title":1347},{"VI":1200},[],{},{"title":1351},{"VI":1352},"Fabio Muttin",{"id":1354,"sortIndex":306,"researcher":22,"roles":1355,"affiliations":1356,"properties":1370,"displayName":1372,"givenName":22,"familyName":22},"125f56b4-cdae-4a92-8c0c-68e545431676",[126],[1357,1363],{"id":1187,"sortIndex":83,"affiliation":1358,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1359,"slug":22,"properties":1360,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1362,"statistic":22},[],{"title":1361},{"VI":1192},[],{"id":1195,"sortIndex":141,"affiliation":1364,"properties":1369},{"id":1195,"createTime":22,"updateTime":22,"relativeEntities":1365,"slug":22,"properties":1366,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1368,"statistic":22},[],{"title":1367},{"VI":1200},[],{},{"title":1371},{"VI":1372},"Roberto Bertini",{"id":1374,"sortIndex":556,"researcher":22,"roles":1375,"affiliations":1376,"properties":1390,"displayName":1097,"givenName":22,"familyName":22},"87416504-9934-486d-9e26-2c86bae98ed9",[126],[1377,1383],{"id":1187,"sortIndex":83,"affiliation":1378,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1379,"slug":22,"properties":1380,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1382,"statistic":22},[],{"title":1381},{"VI":1192},[],{"id":1195,"sortIndex":141,"affiliation":1384,"properties":1389},{"id":1195,"createTime":22,"updateTime":22,"relativeEntities":1385,"slug":22,"properties":1386,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1388,"statistic":22},[],{"title":1387},{"VI":1200},[],{},{"title":1391},{"VI":1097},{"id":1393,"sortIndex":572,"researcher":22,"roles":1394,"affiliations":1395,"properties":1409,"displayName":1411,"givenName":22,"familyName":22},"45bdc1dc-9ec8-4374-b540-6e9d30502d11",[126],[1396,1402],{"id":1187,"sortIndex":83,"affiliation":1397,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1398,"slug":22,"properties":1399,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1401,"statistic":22},[],{"title":1400},{"VI":1192},[],{"id":1195,"sortIndex":141,"affiliation":1403,"properties":1408},{"id":1195,"createTime":22,"updateTime":22,"relativeEntities":1404,"slug":22,"properties":1405,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1407,"statistic":22},[],{"title":1406},{"VI":1200},[],{},{"title":1410},{"VI":1411},"Andrea Salonia",{"id":1413,"sortIndex":586,"researcher":22,"roles":1414,"affiliations":1415,"properties":1424,"displayName":1426,"givenName":22,"familyName":22},"dc94318c-4305-4d86-bd51-324db9005f65",[126],[1416],{"id":1417,"sortIndex":83,"affiliation":1418,"properties":22},"447070fb-b0cd-4eba-8bb8-7c8f48d5ffba",{"id":1417,"createTime":22,"updateTime":22,"relativeEntities":1419,"slug":22,"properties":1420,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1423,"statistic":22},[],{"title":1421},{"VI":1422},"Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy",[],{"title":1425},{"VI":1426},"Luca Rampoldi",{"id":1428,"sortIndex":600,"researcher":22,"roles":1429,"affiliations":1430,"properties":1444,"displayName":1110,"givenName":22,"familyName":22},"0f2db923-d763-447c-85bd-120c4ee0ab46",[126],[1431,1437],{"id":1187,"sortIndex":83,"affiliation":1432,"properties":22},{"id":1187,"createTime":22,"updateTime":22,"relativeEntities":1433,"slug":22,"properties":1434,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1436,"statistic":22},[],{"title":1435},{"VI":1192},[],{"id":1195,"sortIndex":141,"affiliation":1438,"properties":1443},{"id":1195,"createTime":22,"updateTime":22,"relativeEntities":1439,"slug":22,"properties":1440,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1442,"statistic":22},[],{"title":1441},{"VI":1200},[],{},{"title":1445},{"VI":1110},{"url":1180,"publisher":1447,"properties":1489},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1448,"slug":10,"properties":1449,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":1453,"manageAffiliations":1458,"indexDatabases":1469,"url":81,"thumbnailPath":22,"statistic":1484,"gsStatistic":22,"type":22,"analyzePriority":22},[],{"issn":1450,"title":1451,"country":1452},{"VOID":15},{"EN":17},{"VOID":13},[1454],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":1455,"label":1456,"description":1457,"parentId":22,"standard":22,"scholarHubFieldId":22},[],{"EN":29},{},[1459,1464],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":1460,"slug":22,"properties":1461,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1463,"statistic":22},[],{"title":1462},{"EN":37},[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":1465,"slug":22,"properties":1466,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1468,"statistic":22},[],{"title":1467},{"EN":44},[],[1470,1477],{"id":48,"indexDatabase":1471,"url":61,"indexYears":22,"academicFieldIds":1476,"indexDatabaseRanking":22},{"id":50,"createTime":22,"updateTime":22,"relativeEntities":1472,"label":1473,"description":1474,"key":57,"publicationTags":1475,"standard":22},[],{"EN":53,"VI":53},{"EN":55,"VI":56},[59,60],[63],{"id":65,"indexDatabase":1478,"url":76,"indexYears":77,"academicFieldIds":1483,"indexDatabaseRanking":80},{"id":67,"createTime":22,"updateTime":22,"relativeEntities":1479,"label":1480,"description":1481,"key":73,"publicationTags":1482,"standard":22},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79],{"impactFactor":83,"impactFactorByYear":1485,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":1486,"totalCitation":83,"totalCitationByYear":1487,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":1488,"hindexLast5Year":83,"hindex":83},{},{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},{},{},{"pages":1490,"volume":1492},{"VOID":1491},"262-265",{"VOID":1493},"5",{"total":83,"publishYear":1495,"statisticByYear":1496},2019,{},"2019-03-01","2026-04-11T12:11:27.204+00:00",[59,80],{"id":1501,"createTime":1502,"updateTime":1503,"relativeEntities":1504,"slug":1505,"properties":1506,"entityType":117,"verifyStatus":118,"verifyTime":1513,"verifyNote":120,"languages":22,"translateLanguages":22,"viewCount":83,"primaryUrl":1514,"fullTextUrl":22,"authors":1515,"publicationType":318,"publisherRelationship":1752,"citationCount":83,"citationInfo":1799,"publishDate":1801,"publishYear":368,"citationAnalyzeStatus":21,"lastCitationAnalyze":1503,"indexDatabases":1802,"openAccess":22,"references":1803,"isForceReanalyzing":374},"ca29b9ca-48bb-4c37-802c-6fc905ce1a06","2024-01-03T06:14:29.986+00:00","2026-04-02T07:16:45.640+00:00",[],"Outcomes-of-Salvage-Radical-Prostatectomy-for-M0-Castration-resistant-Recurrent-Prostate-Cancer-A-Reasonable-Option-in-the-Era-of-New-Antiandrogen-Therapies-",{"title":1507,"gsPaper":1509,"doi":1511},{"EN":1508},"Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?",{"VOID":1510},"[\"6266368566956002257\"]",{"VOID":1512},"10.1016\u002Fj.euf.2020.04.005","2024-04-30T02:33:38.088+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS2405456920301036",[1516,1531,1546,1559,1572,1587,1602,1617,1630,1648,1663,1687,1702,1724,1739],{"id":1517,"sortIndex":83,"researcher":22,"roles":1518,"affiliations":1519,"properties":1528,"displayName":1530,"givenName":22,"familyName":22},"b2f8c9aa-e2ec-4ac5-8e2e-666e8c296cee",[126],[1520],{"id":1521,"sortIndex":83,"affiliation":1522,"properties":22},"6d586f2e-c6da-41f6-84ec-e53a07bceb87",{"id":1521,"createTime":22,"updateTime":22,"relativeEntities":1523,"slug":22,"properties":1524,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1527,"statistic":22},[],{"title":1525},{"VI":1526},"Department of Urology, San Giovanni Battista Hospital, Città della Salute e della Scienza, University of Turin, Turin, Italy",[],{"title":1529},{"VI":1530},"Giancarlo Marra",{"id":1532,"sortIndex":141,"researcher":22,"roles":1533,"affiliations":1534,"properties":1541,"displayName":1543,"givenName":22,"familyName":22},"d978c781-e4b9-45cf-a142-3ac546f18e7f",[126],[1535],{"id":1521,"sortIndex":83,"affiliation":1536,"properties":22},{"id":1521,"createTime":22,"updateTime":22,"relativeEntities":1537,"slug":22,"properties":1538,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1540,"statistic":22},[],{"title":1539},{"VI":1526},[],{"title":1542,"gsAuthor":1544},{"VI":1543},"Giorgio Calleris",{"VOID":1545},"[\"eQDHxEUAAAAJ\"]",{"id":1547,"sortIndex":165,"researcher":22,"roles":1548,"affiliations":1549,"properties":1556,"displayName":1558,"givenName":22,"familyName":22},"2605fa19-3707-4b51-a0ec-3a4bb82ade39",[126],[1550],{"id":1521,"sortIndex":83,"affiliation":1551,"properties":22},{"id":1521,"createTime":22,"updateTime":22,"relativeEntities":1552,"slug":22,"properties":1553,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1555,"statistic":22},[],{"title":1554},{"VI":1526},[],{"title":1557},{"VI":1558},"Paolo Alessio",{"id":1560,"sortIndex":197,"researcher":22,"roles":1561,"affiliations":1562,"properties":1569,"displayName":1571,"givenName":22,"familyName":22},"334c3694-bf17-4fdf-be47-de80f6abc398",[126],[1563],{"id":1521,"sortIndex":83,"affiliation":1564,"properties":22},{"id":1521,"createTime":22,"updateTime":22,"relativeEntities":1565,"slug":22,"properties":1566,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1568,"statistic":22},[],{"title":1567},{"VI":1526},[],{"title":1570},{"VI":1571},"Marco Oderda",{"id":1573,"sortIndex":211,"researcher":22,"roles":1574,"affiliations":1575,"properties":1584,"displayName":1586,"givenName":22,"familyName":22},"112bc8de-dca7-4c3c-a1a2-a0c7d89e05eb",[126],[1576],{"id":1577,"sortIndex":83,"affiliation":1578,"properties":22},"92c42e51-ddb0-4d6a-b0ca-c8f8cbe3ee01",{"id":1577,"createTime":22,"updateTime":22,"relativeEntities":1579,"slug":22,"properties":1580,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1583,"statistic":22},[],{"title":1581},{"VI":1582},"Department of Urology, Fundaciò Puigvert, Barcelona, Spain",[],{"title":1585},{"VI":1586},"Juan Palou",{"id":1588,"sortIndex":227,"researcher":22,"roles":1589,"affiliations":1590,"properties":1599,"displayName":1601,"givenName":22,"familyName":22},"15f88a7f-1bc3-4076-b14b-5a5d400b2526",[126],[1591],{"id":1592,"sortIndex":83,"affiliation":1593,"properties":22},"520fd7a5-7309-422d-9611-9093d216c65e",{"id":1592,"createTime":22,"updateTime":22,"relativeEntities":1594,"slug":22,"properties":1595,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1598,"statistic":22},[],{"title":1596},{"VI":1597},"Department of Urology, Leuven University Hospitals, Leuven, Belgium",[],{"title":1600},{"VI":1601},"Steven Joniau",{"id":1603,"sortIndex":241,"researcher":22,"roles":1604,"affiliations":1605,"properties":1614,"displayName":1616,"givenName":22,"familyName":22},"5ac1a7e8-feff-4cac-b9c6-35f545188d51",[126],[1606],{"id":1607,"sortIndex":83,"affiliation":1608,"properties":22},"5836f6f8-e522-4be4-9bba-a4327b9b8661",{"id":1607,"createTime":22,"updateTime":22,"relativeEntities":1609,"slug":22,"properties":1610,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1613,"statistic":22},[],{"title":1611},{"VI":1612},"Department of Urology, Clinique Saint Augustin, Bordeaux, France",[],{"title":1615},{"VI":1616},"Thierry Piechaud",{"id":1618,"sortIndex":264,"researcher":22,"roles":1619,"affiliations":1620,"properties":1627,"displayName":1629,"givenName":22,"familyName":22},"e08214b4-4d26-4650-9dc1-d9318b4fd563",[126],[1621],{"id":1607,"sortIndex":83,"affiliation":1622,"properties":22},{"id":1607,"createTime":22,"updateTime":22,"relativeEntities":1623,"slug":22,"properties":1624,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1626,"statistic":22},[],{"title":1625},{"VI":1612},[],{"title":1628},{"VI":1629},"Salvatore Smelzo",{"id":1631,"sortIndex":278,"researcher":22,"roles":1632,"affiliations":1633,"properties":1645,"displayName":1647,"givenName":22,"familyName":22},"d866b4a5-08dc-4cba-ab4d-a741c697e62e",[126],[1634],{"id":1635,"sortIndex":83,"affiliation":1636,"properties":1642},"da81726c-a35d-4b3b-b929-6cade867f88b",{"id":1635,"createTime":22,"updateTime":22,"relativeEntities":1637,"slug":22,"properties":1638,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1641,"statistic":22},[],{"title":1639},{"EN":1640},"Department of Urology, Mayo Clinic, Rochester, MN, United States",[],{"title":1643},{"VI":1644},"Department of Urology, Mayo Clinic, Rochester, MN, USA",{"title":1646},{"VI":1647},"Alessandro Morlacco",{"id":1649,"sortIndex":292,"researcher":22,"roles":1650,"affiliations":1651,"properties":1660,"displayName":1662,"givenName":22,"familyName":22},"b9fdd7f9-27a9-45e8-9126-00b5baa01105",[126],[1652],{"id":1635,"sortIndex":83,"affiliation":1653,"properties":1658},{"id":1635,"createTime":22,"updateTime":22,"relativeEntities":1654,"slug":22,"properties":1655,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1657,"statistic":22},[],{"title":1656},{"EN":1640},[],{"title":1659},{"VI":1644},{"title":1661},{"VI":1662},"Vidit Sharma",{"id":1664,"sortIndex":306,"researcher":22,"roles":1665,"affiliations":1666,"properties":1684,"displayName":1686,"givenName":22,"familyName":22},"ec69435a-1d52-48b6-87aa-ea899561987e",[126],[1667,1675],{"id":1668,"sortIndex":83,"affiliation":1669,"properties":22},"603a50ac-006b-4235-8208-09a3e3b12f82",{"id":1668,"createTime":22,"updateTime":22,"relativeEntities":1670,"slug":22,"properties":1671,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1674,"statistic":22},[],{"title":1672},{"VI":1673},"Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany",[],{"id":1676,"sortIndex":141,"affiliation":1677,"properties":1683},"17e5291f-43b6-4db6-8272-25377a12c352",{"id":1676,"createTime":22,"updateTime":22,"relativeEntities":1678,"slug":22,"properties":1679,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1682,"statistic":22},[],{"title":1680},{"VI":1681},"Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany",[],{},{"title":1685},{"VI":1686},"Derya Tilki",{"id":1688,"sortIndex":556,"researcher":22,"roles":1689,"affiliations":1690,"properties":1699,"displayName":1701,"givenName":22,"familyName":22},"994a4ff6-8894-48b8-bb3d-c86df09ce2ea",[126],[1691],{"id":1692,"sortIndex":83,"affiliation":1693,"properties":22},"ebbe848f-e2ae-437b-bf93-00e074f3be18",{"id":1692,"createTime":22,"updateTime":22,"relativeEntities":1694,"slug":22,"properties":1695,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1698,"statistic":22},[],{"title":1696},{"VI":1697},"Department of Surgical Oncology and Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands",[],{"title":1700},{"VI":1701},"Henk Van der Poel",{"id":1703,"sortIndex":572,"researcher":22,"roles":1704,"affiliations":1705,"properties":1721,"displayName":1723,"givenName":22,"familyName":22},"f5adb9ff-8def-41c8-9313-d3dcd6bc8493",[126],[1706,1712],{"id":1692,"sortIndex":83,"affiliation":1707,"properties":22},{"id":1692,"createTime":22,"updateTime":22,"relativeEntities":1708,"slug":22,"properties":1709,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1711,"statistic":22},[],{"title":1710},{"VI":1697},[],{"id":1713,"sortIndex":141,"affiliation":1714,"properties":1720},"e5e38b97-bc17-47a3-8753-4dd6d4cf396c",{"id":1713,"createTime":22,"updateTime":22,"relativeEntities":1715,"slug":22,"properties":1716,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1719,"statistic":22},[],{"title":1717},{"VI":1718},"Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands",[],{},{"title":1722},{"VI":1723},"Hans Veerman",{"id":1725,"sortIndex":586,"researcher":22,"roles":1726,"affiliations":1727,"properties":1736,"displayName":1738,"givenName":22,"familyName":22},"2ad11940-6aa1-4d76-909a-9150d8faba39",[126],[1728],{"id":1635,"sortIndex":83,"affiliation":1729,"properties":1734},{"id":1635,"createTime":22,"updateTime":22,"relativeEntities":1730,"slug":22,"properties":1731,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1733,"statistic":22},[],{"title":1732},{"EN":1640},[],{"title":1735},{"VI":1644},{"title":1737},{"VI":1738},"R. Jeffrey Karnes",{"id":1740,"sortIndex":600,"researcher":22,"roles":1741,"affiliations":1742,"properties":1749,"displayName":1751,"givenName":22,"familyName":22},"a6eaa06a-d839-4d27-8c5d-0baec6ebbec4",[126],[1743],{"id":1521,"sortIndex":83,"affiliation":1744,"properties":22},{"id":1521,"createTime":22,"updateTime":22,"relativeEntities":1745,"slug":22,"properties":1746,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1748,"statistic":22},[],{"title":1747},{"VI":1526},[],{"title":1750},{"VI":1751},"Paolo Gontero",{"url":1514,"publisher":1753,"properties":1795},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1754,"slug":10,"properties":1755,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":1759,"manageAffiliations":1764,"indexDatabases":1775,"url":81,"thumbnailPath":22,"statistic":1790,"gsStatistic":22,"type":22,"analyzePriority":22},[],{"issn":1756,"title":1757,"country":1758},{"VOID":15},{"EN":17},{"VOID":13},[1760],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":1761,"label":1762,"description":1763,"parentId":22,"standard":22,"scholarHubFieldId":22},[],{"EN":29},{},[1765,1770],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":1766,"slug":22,"properties":1767,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1769,"statistic":22},[],{"title":1768},{"EN":37},[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":1771,"slug":22,"properties":1772,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1774,"statistic":22},[],{"title":1773},{"EN":44},[],[1776,1783],{"id":48,"indexDatabase":1777,"url":61,"indexYears":22,"academicFieldIds":1782,"indexDatabaseRanking":22},{"id":50,"createTime":22,"updateTime":22,"relativeEntities":1778,"label":1779,"description":1780,"key":57,"publicationTags":1781,"standard":22},[],{"EN":53,"VI":53},{"EN":55,"VI":56},[59,60],[63],{"id":65,"indexDatabase":1784,"url":76,"indexYears":77,"academicFieldIds":1789,"indexDatabaseRanking":80},{"id":67,"createTime":22,"updateTime":22,"relativeEntities":1785,"label":1786,"description":1787,"key":73,"publicationTags":1788,"standard":22},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79],{"impactFactor":83,"impactFactorByYear":1791,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":1792,"totalCitation":83,"totalCitationByYear":1793,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":1794,"hindexLast5Year":83,"hindex":83},{},{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},{},{},{"pages":1796,"volume":1798},{"VOID":1797},"807-811",{"VOID":366},{"total":83,"publishYear":368,"statisticByYear":1800},{},"2021-07-01",[59,80],[1804,1812,1820,1828,1837,1845,1853],{"id":22,"text":1805,"url":1806,"identifiers":1807},"Loriot, 2018, Management of non-metastatic castrate-resistant prostate cancer: a systematic review, Cancer Treat Rev, 70, 223, 10.1016\u002Fj.ctrv.2018.09.006","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.ctrv.2018.09.006",{"mag":1808,"openalex":1809,"pm":1810,"doi":1811},"2890337583","W2890337583","30300771","10.1016\u002Fj.ctrv.2018.09.006",{"id":22,"text":1813,"url":1814,"identifiers":1815},"Smith, 2005, Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer, J Clin Oncol, 23, 2918, 10.1200\u002FJCO.2005.01.529","https:\u002F\u002Fdoi.org\u002F10.1200\u002Fjco.2005.01.529",{"mag":1816,"openalex":1817,"pm":1818,"doi":1819},"2150402649","W2150402649","15860850","10.1200\u002Fjco.2005.01.529",{"id":22,"text":1821,"url":1822,"identifiers":1823},"Smith, 2018, Apalutamide treatment and metastasis-free survival in prostate cancer, N Engl J Med, 378, 1408, 10.1056\u002FNEJMoa1715546","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejmoa1715546",{"mag":1824,"openalex":1825,"pm":1826,"doi":1827},"2792086148","W2792086148","29420164","10.1056\u002Fnejmoa1715546",{"id":22,"text":1829,"url":1830,"identifiers":1831},"Hussain, 2018, Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer, N Engl J Med, 378, 2465, 10.1056\u002FNEJMoa1800536","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejmoa1800536",{"mag":1832,"pmc":1833,"openalex":1834,"pm":1835,"doi":1836},"2810806599","8288034","W2810806599","29949494","10.1056\u002Fnejmoa1800536",{"id":22,"text":1838,"url":1839,"identifiers":1840},"Gontero, 2019, Salvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approaches, J Urol, 202, 725, 10.1097\u002FJU.0000000000000327","https:\u002F\u002Fdoi.org\u002F10.1097\u002Fju.0000000000000327",{"mag":1841,"openalex":1842,"pm":1843,"doi":1844},"2944439673","W2944439673","31075058","10.1097\u002Fju.0000000000000327",{"id":22,"text":1846,"url":1847,"identifiers":1848},"Heidenreich, 2015, The role of palliative surgery in castration-resistant prostate cancer, Oncol Res Treat, 38, 670, 10.1159\u002F000442268","https:\u002F\u002Fdoi.org\u002F10.1159\u002F000442268",{"mag":1849,"openalex":1850,"pm":1851,"doi":1852},"2173678829","W2173678829","26632812","10.1159\u002F000442268",{"id":22,"text":1854,"url":1855,"identifiers":1856},"Gontero, 2014, Salvage radical prostatectomy in nonmetastatic castration-resistant prostate cancer patients who received previous radiotherapy: a feasibility study, Eur Urol, 65, 254, 10.1016\u002Fj.eururo.2013.08.050","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.eururo.2013.08.050",{"mag":1857,"openalex":1858,"pm":1859,"doi":1860},"2010597995","W2010597995","24012205","10.1016\u002Fj.eururo.2013.08.050",{"id":1862,"createTime":1863,"updateTime":1864,"relativeEntities":1865,"slug":1866,"properties":1867,"entityType":117,"verifyStatus":118,"verifyTime":1874,"verifyNote":120,"languages":22,"translateLanguages":22,"viewCount":83,"primaryUrl":1875,"fullTextUrl":22,"authors":1876,"publicationType":318,"publisherRelationship":2185,"citationCount":22,"citationInfo":22,"publishDate":724,"publishYear":722,"citationAnalyzeStatus":21,"lastCitationAnalyze":2232,"indexDatabases":2233,"openAccess":22,"references":2234,"isForceReanalyzing":374},"385d54c9-de0e-421f-8062-ea09cafb57dd","2023-12-19T23:47:30.572+00:00","2025-07-23T11:20:17.053+00:00",[],"Comparative-Genomic-Profiling-of-Matched-Primary-and-Metastatic-Tumors-in-Renal-Cell-Carcinoma",{"title":1868,"gsPaper":1870,"doi":1872},{"EN":1869},"Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma",{"VOID":1871},"[\"468673990744833028\"]",{"VOID":1873},"10.1016\u002Fj.euf.2017.09.016","2024-05-05T18:24:11.140+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS2405456917302377",[1877,1901,1926,1939,1954,1967,1980,2002,2015,2037,2050,2063,2078,2091,2106,2119,2132,2145,2158,2171],{"id":1878,"sortIndex":83,"researcher":22,"roles":1879,"affiliations":1880,"properties":1898,"displayName":1900,"givenName":22,"familyName":22},"5e0064e9-e329-4ab2-95dd-6b29a01fb904",[126],[1881,1889],{"id":1882,"sortIndex":83,"affiliation":1883,"properties":22},"623d5d1c-5ab3-4c59-9ca1-f42a0ecb2e9b",{"id":1882,"createTime":22,"updateTime":22,"relativeEntities":1884,"slug":22,"properties":1885,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1888,"statistic":22},[],{"title":1886},{"VI":1887},"Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA",[],{"id":1890,"sortIndex":141,"affiliation":1891,"properties":1897},"6b927bc3-966a-4099-a1de-c12cb8969ca8",{"id":1890,"createTime":22,"updateTime":22,"relativeEntities":1892,"slug":22,"properties":1893,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1896,"statistic":22},[],{"title":1894},{"VI":1895},"Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA",[],{},{"title":1899},{"VI":1900},"Maria F. Becerra",{"id":1902,"sortIndex":141,"researcher":22,"roles":1903,"affiliations":1904,"properties":1921,"displayName":1923,"givenName":22,"familyName":22},"246d8dd6-0990-4306-acce-3145a9fdf0d9",[126],[1905,1913],{"id":1906,"sortIndex":83,"affiliation":1907,"properties":22},"193c9586-9c09-4550-89ed-c16e68db8107",{"id":1906,"createTime":22,"updateTime":22,"relativeEntities":1908,"slug":22,"properties":1909,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1912,"statistic":22},[],{"title":1910},{"VI":1911},"Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA",[],{"id":1914,"sortIndex":141,"affiliation":1915,"properties":22},"df196452-eb9a-4139-90b8-5c610e2a0100",{"id":1914,"createTime":22,"updateTime":22,"relativeEntities":1916,"slug":22,"properties":1917,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1920,"statistic":22},[],{"title":1918},{"VI":1919},"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA",[],{"title":1922,"gsAuthor":1924},{"VI":1923},"Ed Reznik",{"VOID":1925},"[\"eT_wqM0AAAAJ\"]",{"id":1927,"sortIndex":165,"researcher":22,"roles":1928,"affiliations":1929,"properties":1936,"displayName":1938,"givenName":22,"familyName":22},"92082a0d-8405-40f9-9f52-7b976fd45916",[126],[1930],{"id":749,"sortIndex":83,"affiliation":1931,"properties":22},{"id":749,"createTime":22,"updateTime":22,"relativeEntities":1932,"slug":22,"properties":1933,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1935,"statistic":22},[],{"title":1934},{"VI":754},[],{"title":1937},{"VI":1938},"Almedina Redzematovic",{"id":1940,"sortIndex":197,"researcher":22,"roles":1941,"affiliations":1942,"properties":1951,"displayName":1953,"givenName":22,"familyName":22},"65108f29-822d-4ea7-8dad-d26a64a58e6d",[126],[1943],{"id":1944,"sortIndex":83,"affiliation":1945,"properties":22},"18ec0b2e-e45a-40a1-b030-e5bef1b9788a",{"id":1944,"createTime":22,"updateTime":22,"relativeEntities":1946,"slug":22,"properties":1947,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1950,"statistic":22},[],{"title":1948},{"VI":1949},"Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA",[],{"title":1952},{"VI":1953},"Daniel M. Tennenbaum",{"id":1955,"sortIndex":211,"researcher":22,"roles":1956,"affiliations":1957,"properties":1964,"displayName":1966,"givenName":22,"familyName":22},"75f12675-508f-4a4e-b08e-60f8b53d7939",[126],[1958],{"id":1882,"sortIndex":83,"affiliation":1959,"properties":22},{"id":1882,"createTime":22,"updateTime":22,"relativeEntities":1960,"slug":22,"properties":1961,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1963,"statistic":22},[],{"title":1962},{"VI":1887},[],{"title":1965},{"VI":1966},"Mahyar Kashan",{"id":1968,"sortIndex":227,"researcher":22,"roles":1969,"affiliations":1970,"properties":1977,"displayName":1979,"givenName":22,"familyName":22},"7f39ca54-51db-4a5b-9787-4e10e0194484",[126],[1971],{"id":1882,"sortIndex":83,"affiliation":1972,"properties":22},{"id":1882,"createTime":22,"updateTime":22,"relativeEntities":1973,"slug":22,"properties":1974,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1976,"statistic":22},[],{"title":1975},{"VI":1887},[],{"title":1978},{"VI":1979},"Mazyar Ghanaat",{"id":1981,"sortIndex":241,"researcher":22,"roles":1982,"affiliations":1983,"properties":1999,"displayName":2001,"givenName":22,"familyName":22},"a97f002b-83f7-45c8-b1ec-eb0e7608083e",[126],[1984,1990],{"id":1944,"sortIndex":83,"affiliation":1985,"properties":22},{"id":1944,"createTime":22,"updateTime":22,"relativeEntities":1986,"slug":22,"properties":1987,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1989,"statistic":22},[],{"title":1988},{"VI":1949},[],{"id":1991,"sortIndex":141,"affiliation":1992,"properties":1998},"b29ef28b-2ac1-4634-86da-35cc6d072402",{"id":1991,"createTime":22,"updateTime":22,"relativeEntities":1993,"slug":22,"properties":1994,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":1997,"statistic":22},[],{"title":1995},{"EN":1996},"Department of Urology, Ludwig-Maximilians-University, Munich, Germany",[],{},{"title":2000},{"VI":2001},"Jozefina Casuscelli",{"id":2003,"sortIndex":264,"researcher":22,"roles":2004,"affiliations":2005,"properties":2012,"displayName":2014,"givenName":22,"familyName":22},"c3767178-f094-4ca6-b07d-f1af7899ad9f",[126],[2006],{"id":1882,"sortIndex":83,"affiliation":2007,"properties":22},{"id":1882,"createTime":22,"updateTime":22,"relativeEntities":2008,"slug":22,"properties":2009,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2011,"statistic":22},[],{"title":2010},{"VI":1887},[],{"title":2013},{"VI":2014},"Brandon Manley",{"id":2016,"sortIndex":278,"researcher":22,"roles":2017,"affiliations":2018,"properties":2034,"displayName":2036,"givenName":22,"familyName":22},"ce3fe9ec-3193-48d3-be59-fbe93ffb16e0",[126],[2019,2025],{"id":1914,"sortIndex":83,"affiliation":2020,"properties":22},{"id":1914,"createTime":22,"updateTime":22,"relativeEntities":2021,"slug":22,"properties":2022,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2024,"statistic":22},[],{"title":2023},{"VI":1919},[],{"id":2026,"sortIndex":141,"affiliation":2027,"properties":2033},"0b2f8e2f-4b98-4e76-a27f-7b42bc309c64",{"id":2026,"createTime":22,"updateTime":22,"relativeEntities":2028,"slug":22,"properties":2029,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2032,"statistic":22},[],{"title":2030},{"VI":2031},"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA",[],{},{"title":2035},{"VI":2036},"Philip Jonsson",{"id":2038,"sortIndex":292,"researcher":22,"roles":2039,"affiliations":2040,"properties":2047,"displayName":2049,"givenName":22,"familyName":22},"0c3a7244-d2a9-41c4-aad5-4ac4d957a8dd",[126],[2041],{"id":1944,"sortIndex":83,"affiliation":2042,"properties":22},{"id":1944,"createTime":22,"updateTime":22,"relativeEntities":2043,"slug":22,"properties":2044,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2046,"statistic":22},[],{"title":2045},{"VI":1949},[],{"title":2048},{"VI":2049},"Renzo G. DiNatale",{"id":2051,"sortIndex":306,"researcher":22,"roles":2052,"affiliations":2053,"properties":2060,"displayName":2062,"givenName":22,"familyName":22},"3e0bbc84-b1aa-4fff-b941-2565167e8aeb",[126],[2054],{"id":1882,"sortIndex":83,"affiliation":2055,"properties":22},{"id":1882,"createTime":22,"updateTime":22,"relativeEntities":2056,"slug":22,"properties":2057,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2059,"statistic":22},[],{"title":2058},{"VI":1887},[],{"title":2061},{"VI":2062},"Kyle A. Blum",{"id":2064,"sortIndex":556,"researcher":22,"roles":2065,"affiliations":2066,"properties":2075,"displayName":2077,"givenName":22,"familyName":22},"ee8a7a4a-426d-425b-84cf-04bd4f405313",[126],[2067],{"id":2068,"sortIndex":83,"affiliation":2069,"properties":22},"9c07ee29-23d4-485f-b88b-080352183b26",{"id":2068,"createTime":22,"updateTime":22,"relativeEntities":2070,"slug":22,"properties":2071,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2074,"statistic":22},[],{"title":2072},{"VI":2073},"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA",[],{"title":2076},{"VI":2077},"Jeremy C. Durack",{"id":2079,"sortIndex":572,"researcher":22,"roles":2080,"affiliations":2081,"properties":2088,"displayName":2090,"givenName":22,"familyName":22},"f5c553a6-b440-428a-9165-040dc7acbed3",[126],[2082],{"id":2068,"sortIndex":83,"affiliation":2083,"properties":22},{"id":2068,"createTime":22,"updateTime":22,"relativeEntities":2084,"slug":22,"properties":2085,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2087,"statistic":22},[],{"title":2086},{"VI":2073},[],{"title":2089},{"VI":2090},"Stephen B. Solomon",{"id":2092,"sortIndex":586,"researcher":22,"roles":2093,"affiliations":2094,"properties":2103,"displayName":2105,"givenName":22,"familyName":22},"5cc2d35d-afea-48f8-86d8-1cffae137663",[126],[2095],{"id":2096,"sortIndex":83,"affiliation":2097,"properties":22},"d98dd2b0-b6e0-4282-95fc-48143b1be8fa",{"id":2096,"createTime":22,"updateTime":22,"relativeEntities":2098,"slug":22,"properties":2099,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2102,"statistic":22},[],{"title":2100},{"VI":2101},"Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA",[],{"title":2104},{"VI":2105},"Maria E. Arcila",{"id":2107,"sortIndex":600,"researcher":22,"roles":2108,"affiliations":2109,"properties":2116,"displayName":2118,"givenName":22,"familyName":22},"862b566a-1a35-4344-abd2-39fb9f5ac6f0",[126],[2110],{"id":1906,"sortIndex":83,"affiliation":2111,"properties":22},{"id":1906,"createTime":22,"updateTime":22,"relativeEntities":2112,"slug":22,"properties":2113,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2115,"statistic":22},[],{"title":2114},{"VI":1911},[],{"title":2117},{"VI":2118},"Caitlin Bourque",{"id":2120,"sortIndex":616,"researcher":22,"roles":2121,"affiliations":2122,"properties":2129,"displayName":2131,"givenName":22,"familyName":22},"9c618ec1-dde5-4f41-80da-84fa71b01599",[126],[2123],{"id":1906,"sortIndex":83,"affiliation":2124,"properties":22},{"id":1906,"createTime":22,"updateTime":22,"relativeEntities":2125,"slug":22,"properties":2126,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2128,"statistic":22},[],{"title":2127},{"VI":1911},[],{"title":2130},{"VI":2131},"Nick Socci",{"id":2133,"sortIndex":630,"researcher":22,"roles":2134,"affiliations":2135,"properties":2142,"displayName":2144,"givenName":22,"familyName":22},"1b946870-f388-4bf9-8610-2bee0a23fbd3",[126],[2136],{"id":749,"sortIndex":83,"affiliation":2137,"properties":22},{"id":749,"createTime":22,"updateTime":22,"relativeEntities":2138,"slug":22,"properties":2139,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2141,"statistic":22},[],{"title":2140},{"VI":754},[],{"title":2143},{"VI":2144},"Maria I. Carlo",{"id":2146,"sortIndex":646,"researcher":22,"roles":2147,"affiliations":2148,"properties":2155,"displayName":2157,"givenName":22,"familyName":22},"db7cdd14-06a2-47e3-a962-5e06e1c205f8",[126],[2149],{"id":749,"sortIndex":83,"affiliation":2150,"properties":22},{"id":749,"createTime":22,"updateTime":22,"relativeEntities":2151,"slug":22,"properties":2152,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2154,"statistic":22},[],{"title":2153},{"VI":754},[],{"title":2156},{"VI":2157},"Chung-Han Lee",{"id":2159,"sortIndex":660,"researcher":22,"roles":2160,"affiliations":2161,"properties":2168,"displayName":2170,"givenName":22,"familyName":22},"af444329-de48-45b1-beaa-6a13169dac5e",[126],[2162],{"id":749,"sortIndex":83,"affiliation":2163,"properties":22},{"id":749,"createTime":22,"updateTime":22,"relativeEntities":2164,"slug":22,"properties":2165,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2167,"statistic":22},[],{"title":2166},{"VI":754},[],{"title":2169},{"VI":2170},"Martin H. Voss",{"id":2172,"sortIndex":2173,"researcher":22,"roles":2174,"affiliations":2175,"properties":2182,"displayName":2184,"givenName":22,"familyName":22},"911a8394-3411-486a-8790-1c5668a3574e",19,[126],[2176],{"id":749,"sortIndex":83,"affiliation":2177,"properties":22},{"id":749,"createTime":22,"updateTime":22,"relativeEntities":2178,"slug":22,"properties":2179,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2181,"statistic":22},[],{"title":2180},{"VI":754},[],{"title":2183},{"VI":2184},"Darren R. Feldman",{"url":1875,"publisher":2186,"properties":2228},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2187,"slug":10,"properties":2188,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":2192,"manageAffiliations":2197,"indexDatabases":2208,"url":81,"thumbnailPath":22,"statistic":2223,"gsStatistic":22,"type":22,"analyzePriority":22},[],{"issn":2189,"title":2190,"country":2191},{"VOID":15},{"EN":17},{"VOID":13},[2193],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":2194,"label":2195,"description":2196,"parentId":22,"standard":22,"scholarHubFieldId":22},[],{"EN":29},{},[2198,2203],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":2199,"slug":22,"properties":2200,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2202,"statistic":22},[],{"title":2201},{"EN":37},[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":2204,"slug":22,"properties":2205,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2207,"statistic":22},[],{"title":2206},{"EN":44},[],[2209,2216],{"id":48,"indexDatabase":2210,"url":61,"indexYears":22,"academicFieldIds":2215,"indexDatabaseRanking":22},{"id":50,"createTime":22,"updateTime":22,"relativeEntities":2211,"label":2212,"description":2213,"key":57,"publicationTags":2214,"standard":22},[],{"EN":53,"VI":53},{"EN":55,"VI":56},[59,60],[63],{"id":65,"indexDatabase":2217,"url":76,"indexYears":77,"academicFieldIds":2222,"indexDatabaseRanking":80},{"id":67,"createTime":22,"updateTime":22,"relativeEntities":2218,"label":2219,"description":2220,"key":73,"publicationTags":2221,"standard":22},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79],{"impactFactor":83,"impactFactorByYear":2224,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":2225,"totalCitation":83,"totalCitationByYear":2226,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":2227,"hindexLast5Year":83,"hindex":83},{},{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},{},{},{"pages":2229,"volume":2231},{"VOID":2230},"986-994",{"VOID":719},"2025-07-23T11:20:17.052+00:00",[59,80],[2235,2243,2251,2259,2268,2274,2282,2291,2299,2308,2316,2325,2331,2340,2349,2358,2363,2372,2378,2387,2395,2404,2413,2422,2428,2437,2446,2454,2463,2469],{"id":22,"text":2236,"url":2237,"identifiers":2238},"Hsieh, 2017, Renal cell carcinoma, Nat Rev Dis Primers, 3, 17009, 10.1038\u002Fnrdp.2017.9","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejm199609193351207",{"mag":2239,"openalex":2240,"pm":2241,"doi":2242},"2768600953","W2768600953","8778606","10.1056\u002Fnejm199609193351207",{"id":22,"text":2244,"url":2245,"identifiers":2246},"Choueiri, 2017, Systemic therapy for metastatic renal-cell carcinoma, N Engl J Med, 376, 354, 10.1056\u002FNEJMra1601333","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejmra1601333",{"mag":2247,"openalex":2248,"pm":2249,"doi":2250},"2614480329","W2614480329","28121507","10.1056\u002Fnejmra1601333",{"id":22,"text":2252,"url":2253,"identifiers":2254},"The Cancer Genome Atlas Research Network, 2013, Comprehensive molecular characterization of clear cell renal cell carcinoma, Nature, 499, 43, 10.1038\u002Fnature12222","https:\u002F\u002Fdoi.org\u002F10.1038\u002Fnature12222",{"mag":2255,"openalex":2256,"pm":2257,"doi":2258},"2335012284","W2335012284","23792563","10.1038\u002Fnature12222",{"id":22,"text":2260,"url":2261,"identifiers":2262},"The Cancer Genome Atlas Research Network, 2016, Comprehensive molecular characterization of papillary renal-cell carcinoma, N Engl J Med, 374, 135, 10.1056\u002FNEJMoa1505917","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejmoa1505917",{"mag":2263,"pmc":2264,"openalex":2265,"pm":2266,"doi":2267},"2111867681","4775252","W2111867681","26536169","10.1056\u002Fnejmoa1505917",{"id":2269,"text":2270,"url":2271,"identifiers":2272},"75b875a1-b42f-460b-bb14-ecc3ec98b583","Davis, 2014, The somatic genomic landscape of chromophobe renal cell carcinoma, Cancer Cell, 26, 319, 10.1016\u002Fj.ccr.2014.07.014","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1535610814003043",{"doi":2273},"10.1016\u002Fj.ccr.2014.07.014",{"id":22,"text":2275,"url":2276,"identifiers":2277},"Hakimi, 2013, A clear picture of renal cell carcinoma, Nat Genet, 45, 849, 10.1038\u002Fng.2708","https:\u002F\u002Fdoi.org\u002F10.1038\u002Fng.2708",{"mag":2278,"openalex":2279,"pm":2280,"doi":2281},"2002619034","W2002619034","23892664","10.1038\u002Fng.2708",{"id":22,"text":2283,"url":2284,"identifiers":2285},"Xu, 2016, Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin, J Clin Invest, 126, 3526, 10.1172\u002FJCI86120","https:\u002F\u002Fdoi.org\u002F10.1172\u002Fjci86120",{"mag":2286,"pmc":2287,"openalex":2288,"pm":2289,"doi":2290},"2498858397","5004947","W2498858397","27482884","10.1172\u002Fjci86120",{"id":22,"text":2292,"url":2293,"identifiers":2294},"Shuch, 2015, Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity, Eur Urol, 67, 85, 10.1016\u002Fj.eururo.2014.04.029","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.eururo.2014.04.029",{"mag":2295,"openalex":2296,"pm":2297,"doi":2298},"2064072638","W2064072638","24857407","10.1016\u002Fj.eururo.2014.04.029",{"id":22,"text":2300,"url":2301,"identifiers":2302},"Sankin, 2015, Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies, Front Oncol, 5, 67, 10.3389\u002Ffonc.2015.00067","https:\u002F\u002Fdoi.org\u002F10.3389\u002Ffonc.2015.00067",{"mag":2303,"pmc":2304,"openalex":2305,"pm":2306,"doi":2307},"2021547313","4389537","W2021547313","25905038","10.3389\u002Ffonc.2015.00067",{"id":22,"text":2309,"url":2310,"identifiers":2311},"Fernandez-Pello, 2017, A systematic review and meta-analysis comparing the effectiveness and adverse effects of different systemic treatments for non-clear cell renal cell carcinoma, Eur Urol, 71, 426, 10.1016\u002Fj.eururo.2016.11.020","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.eururo.2016.11.020",{"mag":2312,"openalex":2313,"pm":2314,"doi":2315},"2560219063","W2560219063","27939075","10.1016\u002Fj.eururo.2016.11.020",{"id":22,"text":2317,"url":2318,"identifiers":2319},"Chen, 2016, Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets, Nat Commun, 7, 13131, 10.1038\u002Fncomms13131","https:\u002F\u002Fdoi.org\u002F10.1038\u002Fncomms13131",{"mag":2320,"pmc":2321,"openalex":2322,"pm":2323,"doi":2324},"2529393194","5059781","W2529393194","27713405","10.1038\u002Fncomms13131",{"id":2326,"text":2327,"url":2328,"identifiers":2329},"9ef1e041-d59b-4c21-8721-a046203ee007","Hsieh, 2017, Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: a braided cancer river model of kidney cancer, Semin Cell Dev Biol, 64, 98, 10.1016\u002Fj.semcdb.2016.09.002","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1084952116302865",{"doi":2330},"10.1016\u002Fj.semcdb.2016.09.002",{"id":22,"text":2332,"url":2333,"identifiers":2334},"Gerlinger, 2012, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing, N Engl J Med, 366, 883, 10.1056\u002FNEJMoa1113205","https:\u002F\u002Fdoi.org\u002F10.1056\u002Fnejmoa1113205",{"mag":2335,"pmc":2336,"openalex":2337,"pm":2338,"doi":2339},"2150575159","4878653","W2150575159","22397650","10.1056\u002Fnejmoa1113205",{"id":22,"text":2341,"url":2342,"identifiers":2343},"Gerlinger, 2014, Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing, Nat Genet, 46, 225, 10.1038\u002Fng.2891","https:\u002F\u002Fdoi.org\u002F10.1038\u002Fng.2891",{"mag":2344,"pmc":2345,"openalex":2346,"pm":2347,"doi":2348},"1968657935","4636053","W1968657935","24487277","10.1038\u002Fng.2891",{"id":22,"text":2350,"url":2351,"identifiers":2352},"Voss, 2014, Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy, Clin Cancer Res, 20, 1955, 10.1158\u002F1078-0432.CCR-13-2345","https:\u002F\u002Fdoi.org\u002F10.1158\u002F1078-0432.ccr-13-2345",{"mag":2353,"pmc":2354,"openalex":2355,"pm":2356,"doi":2357},"2148424438","4140619","W2148424438","24622468","10.1158\u002F1078-0432.ccr-13-2345",{"id":22,"text":2359,"url":2360,"identifiers":2361},"Zehir, 2017, Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients, Nat Med, 23, 703, 10.1038\u002Fnm.4333","http:\u002F\u002Fdx.doi.org\u002F10.1038\u002Fnm.4333",{"doi":2362},"10.1038\u002Fnm.4333",{"id":22,"text":2364,"url":2365,"identifiers":2366},"Hakimi, 2013, Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network, Clin Cancer Res, 19, 3259, 10.1158\u002F1078-0432.CCR-12-3886","https:\u002F\u002Fdoi.org\u002F10.1158\u002F1078-0432.ccr-12-3886",{"mag":2367,"pmc":2368,"openalex":2369,"pm":2370,"doi":2371},"2158290434","3708609","W2158290434","23620406","10.1158\u002F1078-0432.ccr-12-3886",{"id":2373,"text":2374,"url":2375,"identifiers":2376},"d46395b2-8073-4e98-b50f-f429f4fe0d16","Collins, 2015, A new initiative on precision medicine, N Engl J Med, 372, 793, 10.1056\u002FNEJMp1500523","http:\u002F\u002Fwww.nejm.org\u002Fdoi\u002F10.1056\u002FNEJMp1500523",{"doi":2377},"10.1056\u002Fnejmp1500523",{"id":22,"text":2379,"url":2380,"identifiers":2381},"Chen, 2016, Multilevel genomics-based taxonomy of renal cell carcinoma, Cell Rep, 14, 2476, 10.1016\u002Fj.celrep.2016.02.024","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.celrep.2016.02.024",{"mag":2382,"pmc":2383,"openalex":2384,"pm":2385,"doi":2386},"2288944226","4794376","W2288944226","26947078","10.1016\u002Fj.celrep.2016.02.024",{"id":22,"text":2388,"url":2389,"identifiers":2390},"Sato, 2013, Integrated molecular analysis of clear-cell renal cell carcinoma, Nat Genet, 45, 860, 10.1038\u002Fng.2699","https:\u002F\u002Fdoi.org\u002F10.1038\u002Fng.2699",{"mag":2391,"openalex":2392,"pm":2393,"doi":2394},"2096172976","W2096172976","23797736","10.1038\u002Fng.2699",{"id":22,"text":2396,"url":2397,"identifiers":2398},"Durinck, 2015, Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes, Nat Genet, 47, 13, 10.1038\u002Fng.3146","https:\u002F\u002Fdoi.org\u002F10.1038\u002Fng.3146",{"mag":2399,"pmc":2400,"openalex":2401,"pm":2402,"doi":2403},"2068059571","4489427","W2068059571","25401301","10.1038\u002Fng.3146",{"id":22,"text":2405,"url":2406,"identifiers":2407},"Voss, 2016, Therapeutic guide for mTOuRing through the braided kidney cancer genomic river, Clin Cancer Res, 22, 2320, 10.1158\u002F1078-0432.CCR-16-0035","https:\u002F\u002Fdoi.org\u002F10.1158\u002F1078-0432.ccr-16-0035",{"mag":2408,"pmc":2409,"openalex":2410,"pm":2411,"doi":2412},"2278880357","5431075","W2278880357","26920890","10.1158\u002F1078-0432.ccr-16-0035",{"id":22,"text":2414,"url":2415,"identifiers":2416},"Kwiatkowski, 2016, Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma, Clin Cancer Res, 22, 2445, 10.1158\u002F1078-0432.CCR-15-2631","https:\u002F\u002Fdoi.org\u002F10.1158\u002F1078-0432.ccr-15-2631",{"mag":2417,"pmc":2418,"openalex":2419,"pm":2420,"doi":2421},"2263864814","4976069","W2263864814","26831717","10.1158\u002F1078-0432.ccr-15-2631",{"id":2423,"text":2424,"url":2425,"identifiers":2426},"8b9c0397-76db-4c7f-b431-c42a13e48880","Hsieh, 2017, Genomic biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma, Eur Urol, 71, 405, 10.1016\u002Fj.eururo.2016.10.007","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0302283816307011",{"doi":2427},"10.1016\u002Fj.eururo.2016.10.007",{"id":22,"text":2429,"url":2430,"identifiers":2431},"Lim, 2016, Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus, Oncotarget, 7, 10547, 10.18632\u002Foncotarget.7234","https:\u002F\u002Fdoi.org\u002F10.18632\u002Foncotarget.7234",{"mag":2432,"pmc":2433,"openalex":2434,"pm":2435,"doi":2436},"2262992659","4891139","W2262992659","26859683","10.18632\u002Foncotarget.7234",{"id":22,"text":2438,"url":2439,"identifiers":2440},"Sankin, 2014, The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling, Cancer Med, 3, 1485, 10.1002\u002Fcam4.293","https:\u002F\u002Fdoi.org\u002F10.1002\u002Fcam4.293",{"mag":2441,"pmc":2442,"openalex":2443,"pm":2444,"doi":2445},"2050533285","4298374","W2050533285","25124064","10.1002\u002Fcam4.293",{"id":22,"text":2447,"url":2448,"identifiers":2449},"Venkatesan, 2016, Tumor evolutionary principles: how intratumor heterogeneity influences cancer treatment and outcome, Am Soc Clin Oncol Educ Book, 35, e141, 10.1200\u002FEDBK_158930","https:\u002F\u002Fdoi.org\u002F10.14694\u002Fedbk_158930",{"mag":2450,"openalex":2451,"pm":2452,"doi":2453},"2416255737","W2416255737","27249716","10.14694\u002Fedbk_158930",{"id":22,"text":2455,"url":2456,"identifiers":2457},"Eckel-Passow, 2017, BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor, BMC Urol, 17, 19, 10.1186\u002Fs12894-017-0209-3","https:\u002F\u002Fdoi.org\u002F10.1186\u002Fs12894-017-0209-3",{"mag":2458,"pmc":2459,"openalex":2460,"pm":2461,"doi":2462},"2602237282","5361787","W2602237282","28327121","10.1186\u002Fs12894-017-0209-3",{"id":2464,"text":2465,"url":2466,"identifiers":2467},"887bb525-ff3a-4403-806f-283fd3c30f85","Gundem, 2015, The evolutionary history of lethal metastatic prostate cancer, Nature, 520, 353, 10.1038\u002Fnature14347","https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fnature14347",{"doi":2468},"10.1038\u002Fnature14347",{"id":22,"text":2470,"url":2471,"identifiers":2472},"Wei, 2015, A river model to map convergent cancer evolution and guide therapy in RCC, Nat Rev Urol, 12, 706, 10.1038\u002Fnrurol.2015.260","https:\u002F\u002Fdoi.org\u002F10.1038\u002Fnrurol.2015.260",{"mag":2473,"openalex":2474,"pm":2475,"doi":2476},"2193985236","W2193985236","26526752","10.1038\u002Fnrurol.2015.260",{"id":2478,"createTime":2479,"updateTime":2480,"relativeEntities":2481,"slug":2482,"properties":2483,"entityType":117,"verifyStatus":118,"verifyTime":2480,"verifyNote":120,"languages":22,"translateLanguages":22,"viewCount":83,"primaryUrl":2490,"fullTextUrl":22,"authors":2491,"publicationType":318,"publisherRelationship":2550,"citationCount":22,"citationInfo":22,"publishDate":2597,"publishYear":1495,"citationAnalyzeStatus":21,"lastCitationAnalyze":22,"indexDatabases":2598,"openAccess":22,"references":22,"isForceReanalyzing":374},"f5f7df20-8eb5-4057-b545-dff5f94af7db","2023-12-23T00:43:05.614+00:00","2025-02-27T01:27:32.265+00:00",[],"Taxane-based-Combination-Therapies-for-Metastatic-Prostate-Cancer",{"title":2484,"references":2486,"doi":2488},{"EN":2485},"Taxane-based Combination Therapies for Metastatic Prostate Cancer",{"VOID":2487},"National Comprehensive Cancer Network, 2017\nVaishampayan, 2014, Therapeutic options and multifaceted treatment paradigms in metastatic castrate-resistant prostate cancer, Curr Opin Oncol, 26, 265, 10.1097\u002FCCO.0000000000000066\nTannock, 2004, Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer, N Engl J Med, 351, 1502, 10.1056\u002FNEJMoa040720\nPetrylak, 2004, Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer, N Engl J Med, 351, 1513, 10.1056\u002FNEJMoa041318\nNational Comprehensive Cancer Network, 2016\nAzarenko, 2014, Antiproliferative mechanism of action of the novel taxane cabazitaxel as compared with the parent compound docetaxel in MCF7 breast cancer cells, Mol Cancer Ther, 13, 2092, 10.1158\u002F1535-7163.MCT-14-0265\nVrignaud, 2013, Preclinical antitumor activity of cabazitaxel, a semi-synthetic taxane active in taxane-resistant tumors, Clin Cancer Res, 19, 2973, 10.1158\u002F1078-0432.CCR-12-3146\nde Bono, 2010, Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial, Lancet, 376, 1147, 10.1016\u002FS0140-6736(10)61389-X\nSartor, 2016, Cabazitaxel vs docetaxel in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: a three-arm phase III study (FIRSTANA), J Clin Oncol, 34, 5006, 10.1200\u002FJCO.2016.34.15_suppl.5006\nEisenberger, 2017, Phase III study comparing a reduced dose of cabazitaxel (20 mg\u002Fm2) and the currently approved dose (25 mg\u002Fm2) in postdocetaxel patients with metastatic castration-resistant prostate cancer—PROSELICA, J Clin Oncol, 35, 3198, 10.1200\u002FJCO.2016.72.1076\nSanofi PI. JEVTANA® (cabazitaxel) injection, prescribing information, FDA. Revised 2017.\nTannock, 1996, Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points, J Clin Oncol, 14, 1756, 10.1200\u002FJCO.1996.14.6.1756\nBerry, 2002, Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer, J Urol, 168, 2439, 10.1016\u002FS0022-5347(05)64163-8\nKantoff, 1999, Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study, J Clin Oncol, 17, 2506, 10.1200\u002FJCO.1999.17.8.2506\nHurwitz, 2015, Chemotherapy in prostate cancer, Curr Oncol Rep, 17, 44, 10.1007\u002Fs11912-015-0468-7\nFizazi, 2007, Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data, Lancet Oncol, 8, 994, 10.1016\u002FS1470-2045(07)70284-X\nRavery, 2011, The use of estramustine phosphate in the modern management of advanced prostate cancer, BJU Int, 108, 1782, 10.1111\u002Fj.1464-410X.2011.10201.x\nSweeney, 2015, Chemohormonal therapy in metastatic hormone-sensitive prostate cancer, N Engl J Med, 373, 737, 10.1056\u002FNEJMoa1503747\nGuise, 2003, Role of endothelin-1 in osteoblastic bone metastases, Cancer, 97, 779, 10.1002\u002Fcncr.11129\nQuinn, 2013, Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial, Lancet Oncol, 14, 893, 10.1016\u002FS1470-2045(13)70294-8\nFizazi, 2013, Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancer, J Clin Oncol, 31, 1740, 10.1200\u002FJCO.2012.46.4149\nAraujo, 2013, Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial, Lancet Oncol, 14, 1307, 10.1016\u002FS1470-2045(13)70479-0\nGoyal, 2012, Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases, Cancer Lett, 323, 135, 10.1016\u002Fj.canlet.2012.04.001\nParker, 2013, Alpha emitter radium-223 and survival in metastatic prostate cancer, N Engl J Med, 369, 213, 10.1056\u002FNEJMoa1213755\nMorris, 2016, Updated results: a phase 1\u002F2a randomized trial of radium -223 + docetaxel versus docetaxel in patients with castration-resistant prostate cancer and bone metastases, J Clin Oncol, 34, 5075, 10.1200\u002FJCO.2016.34.15_suppl.5075\nvan Dodewaard-de-Jong, 2016, A randomized, phase II study of repeated rhenium-188-HEDP (rhenium) combined with docetaxel versus docetaxel alone in castration resistant prostate cancer (CRPC) metastatic to bone: the Taxium II trial, J Clin Oncol, 34, 5081, 10.1200\u002FJCO.2016.34.15_suppl.5081\nBouman-Wammes, 2016, A phase I trial of cabazitaxel plus\u002Fminus rhenium -188-HEDP in patients with metastatic castration-resistant prostate cancer who progressed on or after a docetaxel containing treatment, J Clin Oncol, 34, e16508, 10.1200\u002FJCO.2016.34.15_suppl.e16508\nKelly, 2012, Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401, J Clin Oncol, 30, 1534, 10.1200\u002FJCO.2011.39.4767\nTannock, 2013, Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial, Lancet Oncol, 14, 760, 10.1016\u002FS1470-2045(13)70184-0\nHussain, 2012, J Clin Oncol, 30, 97, 10.1200\u002Fjco.2012.30.5_suppl.97\nPetrylak, 2015, Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial, Lancet Oncol, 16, 417, 10.1016\u002FS1470-2045(15)70025-2\nMadan, 2016, Phase II trial of docetaxel, bevacizumab, lenalidomide, and prednisone in patients with metastatic castration-resistant prostate cancer, BJU Int, 118, 590, 10.1111\u002Fbju.13412\nSmall E, Demkov T, Gerritsen WR, et al. A phase 3 trial of GVAX immunotherapy for prostate cancer in combination with docetaxel versus docetaxel plus prednisone in symptomatic, castration-resistant prostate cancer (CRPC) Abstract 7.\nPrell, 2006, The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration, Cancer Immunol Immunother, 55, 1285, 10.1007\u002Fs00262-005-0116-4\nGarnett, 2008, Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement, Clin Cancer Res, 14, 3536, 10.1158\u002F1078-0432.CCR-07-4025\nBeer, 2015, Autologous dendritic cell immunotherapy (DCVAC\u002FPCa) added to docetaxel chemotherapy in a phase III trial (viable) in men with advanced (mCRPC) prostate cancer, J Immunother Cancer, 3, P164, 10.1186\u002F2051-1426-3-S2-P164\nClinicaltrials.gov. 2016 https:\u002F\u002Fclinicaltrials.gov\u002F\nPodrazil, 2015, Phase I\u002FII clinical trial of dendritic-cell based immunotherapy (DCVAC\u002FPCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer, Oncotarget, 6, 18192, 10.18632\u002Foncotarget.4145\nKantoff, 2010, Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer, J Clin Oncol, 28, 1099, 10.1200\u002FJCO.2009.25.0597\nKantoff, 2017, Revised overall survival analysis of a phase II, randomized, double-blind, controlled study of PROSTVAC in men with metastatic castration-resistant prostate cancer, J Clin Oncol, 35, 124, 10.1200\u002FJCO.2016.69.7748\nKwon, 2014, Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial, Lancet Oncol, 15, 700, 10.1016\u002FS1470-2045(14)70189-5\nBeer, 2017, Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive castration-resistant prostate cancer, J Clin Oncol, 35, 40, 10.1200\u002FJCO.2016.69.1584\nTopalian, 2012, Safety, activity, and immune correlates of anti-PD-1 antibody in cancer, N Engl J Med, 366, 2443, 10.1056\u002FNEJMoa1200690\nGraff, 2016, Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer, Oncotarget, 7, 52810, 10.18632\u002Foncotarget.10547\nGao, 2017, VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer, Nat Med, 23, 551, 10.1038\u002Fnm.4308\nMorris, 2016, Phase Ib study of enzalutamide in combination with docetaxel in men with metastatic castration-resistant prostate cancer, Clin Cancer Res, 22, 3774, 10.1158\u002F1078-0432.CCR-15-2638\nPetrylak, 2015, Phase 1\u002F2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer, Invest New Drugs, 33, 397, 10.1007\u002Fs10637-014-0199-x\nTagawa, 2016, Phase 1b study of abiraterone acetate plus prednisone and docetaxel in patients with metastatic castration-resistant prostate cancer, Eur Urol, 70, 718, 10.1016\u002Fj.eururo.2016.01.028\nDuran, 2015, J Clin Oncol, 33, e16022, 10.1200\u002Fjco.2015.33.15_suppl.e16022\nMassard, 2017, Phase I\u002FII trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone, Ann Oncol, 28, 90, 10.1093\u002Fannonc\u002Fmdw441\nSlovin, 2016, Exploring the role of RB and AR in a phase 2 randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC), J Clin Oncol, 34\nPetrylak, 2013, A phase I\u002FII study of safety and efficacy of orteronel (TAK-700), an oral, investigational, nonsteroidal 17,20-lyase inhibitor, with docetaxel and prednisone (DP) in metastatic castration-resistant prostate cancer (mCRPC): updated phase II results, J Clin Oncol, 31, 59, 10.1200\u002Fjco.2013.31.6_suppl.59\nRoss, 2008, A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel, Cancer, 112, 521, 10.1002\u002Fcncr.23195\nNakabayashi, 2008, Response to docetaxel\u002Fcarboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer, BJU Int, 101, 308, 10.1111\u002Fj.1464-410X.2007.07331.x\nRegan, 2010, Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials, Ann Oncol, 21, 312, 10.1093\u002Fannonc\u002Fmdp308\nDerosa, 2014, Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients, Cancer, 120, 3923, 10.1002\u002Fcncr.28953\nPorsch, 2014, A randomised phase II trial comparing docetaxel plus prednisone with docetaxel plus prednisone plus low-dose cyclophosphamide in castration-resistant prostate cancer, Chemotherapy, 60, 129, 10.1159\u002F000369781\nDhawan, 2016, A multicenter phase 1 study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer, J Clin Oncol, 34, 202, 10.1200\u002Fjco.2016.34.2_suppl.202\nLockhart, 2014, Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors, Invest New Drugs, 32, 1236, 10.1007\u002Fs10637-014-0145-y\nCorn, 2009, Confirmatory analysis to determine associations between platinum-sensitivity and molecular signature of combined tumor suppressor defects and aggressive variant prostate carcinomas (AVPC), J Clin Oncol, 34, 5020\nSternberg, 2009, Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer, Ann Oncol, 20, 1264, 10.1093\u002Fannonc\u002Fmdn784\nSonpavde, 2012, Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer, Ann Oncol, 23, 1803, 10.1093\u002Fannonc\u002Fmdr555\nFizazi, 2016, Final overall survival (OS) from the AFFINITY phase 3 trial of custirsen and cabazitaxel\u002Fprednisone in men with previously treated metastatic castration-resistant prostate cancer (mCRPC), Ann Oncol, 27\nChi, 2015, Phase 3 SYNERGY trial: docetaxel plus\u002Fminus custirsen and overall survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and poor prognosis, J Clin Oncol, 33, 5009, 10.1200\u002Fjco.2015.33.15_suppl.5009\nScher, 2011, Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer, J Clin Oncol, 29, 2191, 10.1200\u002FJCO.2010.32.8815\nDreicer, 2013, A randomized, double-blind, placebo-controlled, phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer, Invest New Drugs, 31, 1044, 10.1007\u002Fs10637-013-9940-0\nde Bono, 2014, Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer, Clin Cancer Res, 20, 1925, 10.1158\u002F1078-0432.CCR-13-1869\nSingal, 2015, Phase I\u002FII study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy, Clin Genitourin Cancer, 13, 22, 10.1016\u002Fj.clgc.2014.07.008\nTso, 2000, Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells, Cancer J, 6, 220\nCraft, 1999, Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process, Cancer Res, 59, 5030\nSweeney, 2016, Long term efficacy and QOL data of chemohormonal therapy (C-HT) in low and high volume hormone naïve metastatic prostate cancer (PrCa): E3805 CHAARTED trial, Ann Oncol, 27\nGravis, 2016, Androgen deprivation therapy (ADT) plus docetaxel versus ADT alone in metastatic non castrate prostate cancer: impact of metastatic burden and long-term survival analysis of the randomized phase 3 GETUG-AFU15 trial, Eur Urol, 70, 256, 10.1016\u002Fj.eururo.2015.11.005\nJames, 2016, Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial, Lancet, 387, 1163, 10.1016\u002FS0140-6736(15)01037-5\nJames, 2017, Abiraterone for prostate cancer not previously treated with hormone therapy, N Engl J Med, 377, 338, 10.1056\u002FNEJMoa1702900\nFizazi, 2017, Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer, N Engl J Med, 377, 352, 10.1056\u002FNEJMoa1704174\nSydes, 2017, Adding abiraterone acetate plus prednisolone (AAP) or docetaxel for patients (pts) with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): directly randomised data from STAMPEDE (NCT 00268476), Ann Oncol, 28\nLavaud, 2016, How should we treat castration-resistant prostate cancer patients who have received androgen deprivation therapy (ADT) plus docetaxel upfront for hormone-sensitive disease? Mature analysis of the GETUG-AFU 15 phase III trial, Ann Oncol, 27, 761P, 10.1093\u002Fannonc\u002Fmdw372.45\nOgura, 2016, Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells, Int J Oncol, 48, 2330, 10.3892\u002Fijo.2016.3482\nFitzpatrick, 2014, Taxane mechanisms of action: potential implications for treatment sequencing in metastatic castration-resistant prostate cancer, Eur Urol, 65, 1198, 10.1016\u002Fj.eururo.2013.07.022\nDarshan, 2011, Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer, Cancer Res, 71, 6019, 10.1158\u002F0008-5472.CAN-11-1417\nZhu, 2010, Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer, Cancer Res, 70, 7992, 10.1158\u002F0008-5472.CAN-10-0585\nKomlodi-Pasztor, 2011, Mitosis is not a key target of microtubule agents in patient tumors, Nat Rev Clin Oncol, 8, 244, 10.1038\u002Fnrclinonc.2010.228\nMateo, 2015, DNA-repair defects and olaparib in metastatic prostate cancer, N Engl J Med, 373, 1697, 10.1056\u002FNEJMoa1506859\nRobinson, 2015, Integrative clinical genomics of advanced prostate cancer, Cell, 161, 1215, 10.1016\u002Fj.cell.2015.05.001\nAntonarakis, 2017, Randomized, noncomparative, phase II trial of early switch from docetaxel to cabazitaxel or vice versa, with integrated biomarker analysis, in men with chemotherapy-naive, metastatic, castration-resistant prostate cancer, J Clin Oncol, 35, 3181, 10.1200\u002FJCO.2017.72.4138\nSonpavde, 2017, Circulating tumor (ct)-DNA alterations in metastatic castration-resistant prostate cancer (mCRPC): association with outcomes and evolution with therapy, J Clin Oncol, 35, 149, 10.1200\u002FJCO.2017.35.6_suppl.149",{"VOID":2489},"10.1016\u002Fj.euf.2017.11.009","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS2405456917302651",[2492,2507,2522,2535],{"id":2493,"sortIndex":83,"researcher":22,"roles":2494,"affiliations":2495,"properties":2504,"displayName":2506,"givenName":22,"familyName":22},"82044cd6-8dda-4151-a545-47c0984d3c34",[126],[2496],{"id":2497,"sortIndex":83,"affiliation":2498,"properties":22},"3e297b50-dfe2-413a-836c-af080350e16c",{"id":2497,"createTime":22,"updateTime":22,"relativeEntities":2499,"slug":22,"properties":2500,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2503,"statistic":22},[],{"title":2501},{"VI":2502},"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",[],{"title":2505},{"VI":2506},"Paul G. Corn",{"id":2508,"sortIndex":141,"researcher":22,"roles":2509,"affiliations":2510,"properties":2519,"displayName":2521,"givenName":22,"familyName":22},"532fdc64-7b1f-4613-85bb-a858b3b6707b",[126],[2511],{"id":2512,"sortIndex":83,"affiliation":2513,"properties":22},"da672c70-3f66-487c-9d36-157e21640449",{"id":2512,"createTime":22,"updateTime":22,"relativeEntities":2514,"slug":22,"properties":2515,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2518,"statistic":22},[],{"title":2516},{"VI":2517},"Department of Medicine, Section of Medical Oncology, University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA",[],{"title":2520},{"VI":2521},"Neeraj Agarwal",{"id":2523,"sortIndex":165,"researcher":22,"roles":2524,"affiliations":2525,"properties":2532,"displayName":2534,"givenName":22,"familyName":22},"b27a9bc7-eb71-441e-938a-41995eac10ba",[126],[2526],{"id":2497,"sortIndex":83,"affiliation":2527,"properties":22},{"id":2497,"createTime":22,"updateTime":22,"relativeEntities":2528,"slug":22,"properties":2529,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2531,"statistic":22},[],{"title":2530},{"VI":2502},[],{"title":2533},{"VI":2534},"John Charles Araujo",{"id":2536,"sortIndex":197,"researcher":22,"roles":2537,"affiliations":2538,"properties":2547,"displayName":2549,"givenName":22,"familyName":22},"2b2afdbb-bf5e-40a2-a6e6-eecedc0ede0c",[126],[2539],{"id":2540,"sortIndex":83,"affiliation":2541,"properties":22},"01265a01-0695-4928-a222-b139097c1734",{"id":2540,"createTime":22,"updateTime":22,"relativeEntities":2542,"slug":22,"properties":2543,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2546,"statistic":22},[],{"title":2544},{"VI":2545},"Genitourinary Oncology Section, Dana Farber Cancer Institute, Boston, MA, USA",[],{"title":2548},{"VI":2549},"Guru Sonpavde",{"url":2490,"publisher":2551,"properties":2593},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2552,"slug":10,"properties":2553,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":2557,"manageAffiliations":2562,"indexDatabases":2573,"url":81,"thumbnailPath":22,"statistic":2588,"gsStatistic":22,"type":22,"analyzePriority":22},[],{"issn":2554,"title":2555,"country":2556},{"VOID":15},{"EN":17},{"VOID":13},[2558],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":2559,"label":2560,"description":2561,"parentId":22,"standard":22,"scholarHubFieldId":22},[],{"EN":29},{},[2563,2568],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":2564,"slug":22,"properties":2565,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2567,"statistic":22},[],{"title":2566},{"EN":37},[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":2569,"slug":22,"properties":2570,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2572,"statistic":22},[],{"title":2571},{"EN":44},[],[2574,2581],{"id":48,"indexDatabase":2575,"url":61,"indexYears":22,"academicFieldIds":2580,"indexDatabaseRanking":22},{"id":50,"createTime":22,"updateTime":22,"relativeEntities":2576,"label":2577,"description":2578,"key":57,"publicationTags":2579,"standard":22},[],{"EN":53,"VI":53},{"EN":55,"VI":56},[59,60],[63],{"id":65,"indexDatabase":2582,"url":76,"indexYears":77,"academicFieldIds":2587,"indexDatabaseRanking":80},{"id":67,"createTime":22,"updateTime":22,"relativeEntities":2583,"label":2584,"description":2585,"key":73,"publicationTags":2586,"standard":22},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79],{"impactFactor":83,"impactFactorByYear":2589,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":2590,"totalCitation":83,"totalCitationByYear":2591,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":2592,"hindexLast5Year":83,"hindex":83},{},{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},{},{},{"pages":2594,"volume":2596},{"VOID":2595},"369-380",{"VOID":1493},"2019-05-01",[59,80],{"id":2600,"createTime":2601,"updateTime":2602,"relativeEntities":2603,"slug":2604,"properties":2605,"entityType":117,"verifyStatus":118,"verifyTime":2612,"verifyNote":120,"languages":22,"translateLanguages":22,"viewCount":83,"primaryUrl":2613,"fullTextUrl":22,"authors":2614,"publicationType":318,"publisherRelationship":2897,"citationCount":22,"citationInfo":22,"publishDate":2944,"publishYear":1160,"citationAnalyzeStatus":21,"lastCitationAnalyze":22,"indexDatabases":2945,"openAccess":22,"references":22,"isForceReanalyzing":374},"6494ca66-0493-41ff-b557-b76979b52f39","2023-12-14T05:58:22.042+00:00","2025-02-27T01:02:52.611+00:00",[],"Initial-Experience-and-Evaluation-of-a-Nomogram-for-Outcome-Prediction-in-Management-of-Medium-sized-1-2-cm-Kidney-Stones",{"title":2606,"references":2608,"doi":2610},{"EN":2607},"Initial Experience and Evaluation of a Nomogram for Outcome Prediction in Management of Medium-sized (1–2 cm) Kidney Stones",{"VOID":2609},"Alivizatos, 2006, Is there still a role for open surgery in the management of renal stones?, Curr Opin Urol, 16, 106, 10.1097\u002F01.mou.0000193379.08857.e7\nMicali, 2009, Laparoscopic simultaneous treatment of peripelvic renal cysts and stones: case series, J Endourol, 23, 1851, 10.1089\u002Fend.2009.0042\nBove, 2009, Laparoscopic ureterolithotomy: a comparison between the transperitoneal and the retroperitoneal approach during the learning curve, J Endourol, 23, 953, 10.1089\u002Fend.2008.0055\nEAU guidelines, 2020\nRosa, 2013, Recent finding and new technologies in nephrolithiasis: a review of the recent literature, BMC Urol, 13, 10, 10.1186\u002F1471-2490-13-10\nMicali, 2009, Dornier Lithotripter S 220 F EMSE: the first report of over 1000 treatments, Urology, 74, 1211, 10.1016\u002Fj.urology.2009.05.101\nSighinolfi, 2008, Extracorporeal shock wave lithotripsy in an elderly population: how to prevent complications and make the treatment safe and effective, J Endourol, 22, 2223, 10.1089\u002Fend.2008.9704\nPearle, 2005, Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less, J Urol, 179, S69\nDonaldson, 2015, Systematic review and meta-analysis of the clinical effectiveness of shock wave lithotripsy, retrograde intrarenal surgery, and percutaneous nephrolithotomy for lower-pole renal stones, Eur Urol, 67, 612, 10.1016\u002Fj.eururo.2014.09.054\nDesai, 2017, Miniaturized percutaneous nephrolithotomy: a decade of paradigm shift in percutaneous renal access, Eur Urol, 72, 236, 10.1016\u002Fj.eururo.2017.02.028\nDe La Rosette, 2012, Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy, Eur Urol, 62, 246, 10.1016\u002Fj.eururo.2012.03.055\nResorlu, 2013, Comparison of retrograde intrarenal surgery, shockwave lithotripsy, and percutaneous nephrolithotomy for treatment of medium-sized radiolucent renal stones, World J Urol, 31, 1581, 10.1007\u002Fs00345-012-0991-1\nOkhunov, 2013, S.T.O.N.E. nephrolithometry: Novel surgical classification system for kidney calculi, Urology, 81, 1154, 10.1016\u002Fj.urology.2012.10.083\nHosmer, 2000\nZlotnik, 2015, A general-purpose nomogram generator for predictive logistic regression models, Stata J, 15, 537, 10.1177\u002F1536867X1501500212\nSteyerberg, 2009\nThomas, 2011, The Guy’s stone score grading the complexity of percutaneous nephrolithotomy procedures, Urology, 78, 277, 10.1016\u002Fj.urology.2010.12.026\nSmith, 2013, A nephrolithometric nomogram to predict treatment success of percutaneous nephrolithotomy, J Urol, 190, 149, 10.1016\u002Fj.juro.2013.01.047\nJeong, 2013, Seoul National University renal stone complexity score for predicting stone-free rate after percutaneous nephrolithotomy, PLoS One, 8, 10.1371\u002Fjournal.pone.0065888\nResorlu, 2012, A new scoring system for predicting stone-free rate after retrograde intrarenal surgery: the “resorlu-Unsal Stone Score.”, Urology, 80, 512, 10.1016\u002Fj.urology.2012.02.072\nSfoungaristos, 2016, External validation of Resorlu–Unsal stone score as predictor of outcomes after retrograde intrarenal surgery, Int Urol Nephrol, 48, 1247, 10.1007\u002Fs11255-016-1311-2\nTran, 2015, Triple D score is a reportable predictor of shockwave lithotripsy stone-free rates, J Endourol, 29, 226, 10.1089\u002Fend.2014.0212\nBagrodia, 2008, Impact of body mass index on cost and clinical outcomes after percutaneous nephrostolithotomy, Urology, 72, 756, 10.1016\u002Fj.urology.2008.06.054\nPatel, 2009, Skin to stone distance is an independent predictor of stone-free status following shockwave lithotripsy, J Endourol, 23, 1383, 10.1089\u002Fend.2009.0394\nKim, 2016, Clinical nomograms to predict stone-free rates after shock-wave lithotripsy: development and internal-validation, PLoS One, 11\nAkman, 2011, Variables that influence operative time during percutaneous nephrolithotomy: an analysis of 1897 cases, J Endourol, 25, 1269, 10.1089\u002Fend.2011.0061\nGiusti, 2007, Miniperc? No, thank you!, Eur Urol, 51, 10.1016\u002Fj.eururo.2006.07.047\nDe, 2015, Percutaneous nephrolithotomy versus retrograde intrarenal surgery: a systematic review and meta-analysis, Eur Urol, 67, 125, 10.1016\u002Fj.eururo.2014.07.003\nWiesenthal, 2011, A comparison of treatment modalities for renal calculi between 100 and 300 mm2: are shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy equivalent?, J Endourol, 25, 481, 10.1089\u002Fend.2010.0208\nMerigot De Treigny, 2015, The cumulated stone diameter: a limited tool for stone burden estimation, Urology, 86, 477, 10.1016\u002Fj.urology.2015.06.018",{"VOID":2611},"10.1016\u002Fj.euf.2020.12.012","2025-02-27T01:02:52.610+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS240545692030314X",[2615,2630,2643,2656,2669,2682,2695,2708,2723,2736,2749,2764,2779,2794,2809,2824,2837,2852,2867,2882],{"id":2616,"sortIndex":83,"researcher":22,"roles":2617,"affiliations":2618,"properties":2627,"displayName":2629,"givenName":22,"familyName":22},"384d26c8-3d36-4e5c-b27e-a8ba565c880e",[126],[2619],{"id":2620,"sortIndex":83,"affiliation":2621,"properties":22},"79ef397d-3f7b-4c88-a0e6-f523549232bf",{"id":2620,"createTime":22,"updateTime":22,"relativeEntities":2622,"slug":22,"properties":2623,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2626,"statistic":22},[],{"title":2624},{"VI":2625},"Department of Urology, Azienda Ospedaliero-Universitaria, Urological Residency School Network, University of Modena & Reggio Emilia, Modena, Italy",[],{"title":2628},{"VI":2629},"Salvatore Micali",{"id":2631,"sortIndex":141,"researcher":22,"roles":2632,"affiliations":2633,"properties":2640,"displayName":2642,"givenName":22,"familyName":22},"31f43d2d-2257-4ccf-86fa-78724ee8fcbf",[126],[2634],{"id":2620,"sortIndex":83,"affiliation":2635,"properties":22},{"id":2620,"createTime":22,"updateTime":22,"relativeEntities":2636,"slug":22,"properties":2637,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2639,"statistic":22},[],{"title":2638},{"VI":2625},[],{"title":2641},{"VI":2642},"Maria Chiara Sighinolfi",{"id":2644,"sortIndex":165,"researcher":22,"roles":2645,"affiliations":2646,"properties":2653,"displayName":2655,"givenName":22,"familyName":22},"844e7d6c-feea-46d6-95ac-6e1b729767ac",[126],[2647],{"id":2620,"sortIndex":83,"affiliation":2648,"properties":22},{"id":2620,"createTime":22,"updateTime":22,"relativeEntities":2649,"slug":22,"properties":2650,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2652,"statistic":22},[],{"title":2651},{"VI":2625},[],{"title":2654},{"VI":2655},"Andrea Iseppi",{"id":2657,"sortIndex":197,"researcher":22,"roles":2658,"affiliations":2659,"properties":2666,"displayName":2668,"givenName":22,"familyName":22},"428b1e68-f2e3-43f4-a287-64f2126c572e",[126],[2660],{"id":2620,"sortIndex":83,"affiliation":2661,"properties":22},{"id":2620,"createTime":22,"updateTime":22,"relativeEntities":2662,"slug":22,"properties":2663,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2665,"statistic":22},[],{"title":2664},{"VI":2625},[],{"title":2667},{"VI":2668},"Elena Morini",{"id":2670,"sortIndex":211,"researcher":22,"roles":2671,"affiliations":2672,"properties":2679,"displayName":2681,"givenName":22,"familyName":22},"acdfdd34-dee2-4972-8b03-a5c6f4db2105",[126],[2673],{"id":2620,"sortIndex":83,"affiliation":2674,"properties":22},{"id":2620,"createTime":22,"updateTime":22,"relativeEntities":2675,"slug":22,"properties":2676,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2678,"statistic":22},[],{"title":2677},{"VI":2625},[],{"title":2680},{"VI":2681},"Tommaso Calcagnile",{"id":2683,"sortIndex":227,"researcher":22,"roles":2684,"affiliations":2685,"properties":2692,"displayName":2694,"givenName":22,"familyName":22},"530cd97b-77d1-4c84-8789-c6b39ecded1c",[126],[2686],{"id":2620,"sortIndex":83,"affiliation":2687,"properties":22},{"id":2620,"createTime":22,"updateTime":22,"relativeEntities":2688,"slug":22,"properties":2689,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2691,"statistic":22},[],{"title":2690},{"VI":2625},[],{"title":2693},{"VI":2694},"Mattia Benedetti",{"id":2696,"sortIndex":241,"researcher":22,"roles":2697,"affiliations":2698,"properties":2705,"displayName":2707,"givenName":22,"familyName":22},"d5e8309d-3851-4661-ae01-07044d7d0d5d",[126],[2699],{"id":2620,"sortIndex":83,"affiliation":2700,"properties":22},{"id":2620,"createTime":22,"updateTime":22,"relativeEntities":2701,"slug":22,"properties":2702,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2704,"statistic":22},[],{"title":2703},{"VI":2625},[],{"title":2706},{"VI":2707},"Marco Ticonosco",{"id":2709,"sortIndex":264,"researcher":22,"roles":2710,"affiliations":2711,"properties":2720,"displayName":2722,"givenName":22,"familyName":22},"478ec705-dcb1-4ec2-b4a7-21329af41fff",[126],[2712],{"id":2713,"sortIndex":83,"affiliation":2714,"properties":22},"0fe92026-29e9-44ba-aa50-e6bf840fedce",{"id":2713,"createTime":22,"updateTime":22,"relativeEntities":2715,"slug":22,"properties":2716,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2719,"statistic":22},[],{"title":2717},{"VI":2718},"Clinical and experimental medicine (CEM), Department of Surgical, Medical, Dental and Morphological Sciences with Interest in Transplant, Oncology and Regenerative Medicine, University of Modena & Reggio Emilia, Modena, Italy",[],{"title":2721},{"VI":2722},"Shaniko Kaleci",{"id":2724,"sortIndex":278,"researcher":22,"roles":2725,"affiliations":2726,"properties":2733,"displayName":2735,"givenName":22,"familyName":22},"f13e02fe-f5d9-4c07-bbd4-97b25ef2e223",[126],[2727],{"id":2620,"sortIndex":83,"affiliation":2728,"properties":22},{"id":2620,"createTime":22,"updateTime":22,"relativeEntities":2729,"slug":22,"properties":2730,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2732,"statistic":22},[],{"title":2731},{"VI":2625},[],{"title":2734},{"VI":2735},"Luigi Bevilacqua",{"id":2737,"sortIndex":292,"researcher":22,"roles":2738,"affiliations":2739,"properties":2746,"displayName":2748,"givenName":22,"familyName":22},"e90aa0de-cac4-495d-9477-818baaf86296",[126],[2740],{"id":2620,"sortIndex":83,"affiliation":2741,"properties":22},{"id":2620,"createTime":22,"updateTime":22,"relativeEntities":2742,"slug":22,"properties":2743,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2745,"statistic":22},[],{"title":2744},{"VI":2625},[],{"title":2747},{"VI":2748},"Stefano Puliatti",{"id":2750,"sortIndex":306,"researcher":22,"roles":2751,"affiliations":2752,"properties":2761,"displayName":2763,"givenName":22,"familyName":22},"c892ee6e-eadf-49bf-bd7b-338713c2b9bb",[126],[2753],{"id":2754,"sortIndex":83,"affiliation":2755,"properties":22},"1e34b93e-c81e-4627-bbc7-e6f1b61d47ba",{"id":2754,"createTime":22,"updateTime":22,"relativeEntities":2756,"slug":22,"properties":2757,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2760,"statistic":22},[],{"title":2758},{"VI":2759},"Department of Urology, Ospedale Sant’Andrea, La Sapienza University, Rome, Italy",[],{"title":2762},{"VI":2763},"Cosimo De Nunzio",{"id":2765,"sortIndex":556,"researcher":22,"roles":2766,"affiliations":2767,"properties":2776,"displayName":2778,"givenName":22,"familyName":22},"26643c51-fd26-44be-a284-f2b3ffa27109",[126],[2768],{"id":2769,"sortIndex":83,"affiliation":2770,"properties":22},"add23f9a-d94b-4566-b6d4-edfdb465cdcd",{"id":2769,"createTime":22,"updateTime":22,"relativeEntities":2771,"slug":22,"properties":2772,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2775,"statistic":22},[],{"title":2773},{"VI":2774},"Department of Urology, University of California, Irvine, Orange, CA, USA",[],{"title":2777},{"VI":2778},"Raphael Arada",{"id":2780,"sortIndex":572,"researcher":22,"roles":2781,"affiliations":2782,"properties":2791,"displayName":2793,"givenName":22,"familyName":22},"fabb5a3f-3dd5-4fe4-8ab1-629224973514",[126],[2783],{"id":2784,"sortIndex":83,"affiliation":2785,"properties":22},"ca88cb36-8ee0-4c27-9233-fc5cdabb42c1",{"id":2784,"createTime":22,"updateTime":22,"relativeEntities":2786,"slug":22,"properties":2787,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2790,"statistic":22},[],{"title":2788},{"VI":2789},"Department of Urology, AORN Antonio Cardarelli, Naples, Italy",[],{"title":2792},{"VI":2793},"Francesco Chiancone",{"id":2795,"sortIndex":586,"researcher":22,"roles":2796,"affiliations":2797,"properties":2806,"displayName":2808,"givenName":22,"familyName":22},"3761fcde-715d-41b9-8287-085a5b0b7e6d",[126],[2798],{"id":2799,"sortIndex":83,"affiliation":2800,"properties":22},"2820de7f-7c70-4ae5-b77a-b3a1fbdb17e1",{"id":2799,"createTime":22,"updateTime":22,"relativeEntities":2801,"slug":22,"properties":2802,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2805,"statistic":22},[],{"title":2803},{"VI":2804},"Department of Urology, Ospedale Civile di Guastalla, Urological Residency School Network, University of Modena & Reggio Emilia, Guastalla, Italy",[],{"title":2807},{"VI":2808},"Davide Campobasso",{"id":2810,"sortIndex":600,"researcher":22,"roles":2811,"affiliations":2812,"properties":2821,"displayName":2823,"givenName":22,"familyName":22},"1ce6ed83-41e5-4c5b-8996-aae8c10c6cb2",[126],[2813],{"id":2814,"sortIndex":83,"affiliation":2815,"properties":22},"823ece8b-ae9c-457b-ab71-223016e89c27",{"id":2814,"createTime":22,"updateTime":22,"relativeEntities":2816,"slug":22,"properties":2817,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2820,"statistic":22},[],{"title":2818},{"VI":2819},"Department of Urology, Tanta University, Tanta, Egypt",[],{"title":2822},{"VI":2823},"Ahmed Eissa",{"id":2825,"sortIndex":616,"researcher":22,"roles":2826,"affiliations":2827,"properties":2834,"displayName":2836,"givenName":22,"familyName":22},"9aedfdb5-2aad-4578-9e3a-f453916ac80b",[126],[2828],{"id":2620,"sortIndex":83,"affiliation":2829,"properties":22},{"id":2620,"createTime":22,"updateTime":22,"relativeEntities":2830,"slug":22,"properties":2831,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2833,"statistic":22},[],{"title":2832},{"VI":2625},[],{"title":2835},{"VI":2836},"Giulia Bonfante",{"id":2838,"sortIndex":630,"researcher":22,"roles":2839,"affiliations":2840,"properties":2849,"displayName":2851,"givenName":22,"familyName":22},"a2ffa300-2e0c-4414-aa39-3efa7271cfd7",[126],[2841],{"id":2842,"sortIndex":83,"affiliation":2843,"properties":22},"b72b6b1e-f558-4c7d-8cee-25a2b8d7232c",{"id":2842,"createTime":22,"updateTime":22,"relativeEntities":2844,"slug":22,"properties":2845,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2848,"statistic":22},[],{"title":2846},{"VI":2847},"Department of Urology, Ospedale Maggiore, Urological Residency School Network, University of Modena & Reggio Emilia, Parma, Italy",[],{"title":2850},{"VI":2851},"Elisa Simonetti",{"id":2853,"sortIndex":646,"researcher":22,"roles":2854,"affiliations":2855,"properties":2864,"displayName":2866,"givenName":22,"familyName":22},"face06c4-cd5e-4b4b-8297-5deb89caed3f",[126],[2856],{"id":2857,"sortIndex":83,"affiliation":2858,"properties":22},"2991c662-da58-4c19-ac03-f5e6e53867e4",{"id":2857,"createTime":22,"updateTime":22,"relativeEntities":2859,"slug":22,"properties":2860,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2863,"statistic":22},[],{"title":2861},{"VI":2862},"Department of Urology, Ospedale di Vaio, Urological Residency School Network, University of Modena & Reggio Emilia, Fidenza, Italy",[],{"title":2865},{"VI":2866},"Michele Cotugno",{"id":2868,"sortIndex":660,"researcher":22,"roles":2869,"affiliations":2870,"properties":2879,"displayName":2881,"givenName":22,"familyName":22},"b67c627e-3bdd-430a-af52-6032bf26dcc7",[126],[2871],{"id":2872,"sortIndex":83,"affiliation":2873,"properties":22},"8ee96edd-b7af-4510-922c-35f579358e54",{"id":2872,"createTime":22,"updateTime":22,"relativeEntities":2874,"slug":22,"properties":2875,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2878,"statistic":22},[],{"title":2876},{"EN":2877},"Department of Urology, Policlinico San Pietro, Ponte San Pietro, Italy",[],{"title":2880},{"VI":2881},"Riccardo Galli",{"id":2883,"sortIndex":2173,"researcher":22,"roles":2884,"affiliations":2885,"properties":2894,"displayName":2896,"givenName":22,"familyName":22},"4c6e8fe6-56af-4ff8-9038-2c7139b80343",[126],[2886],{"id":2887,"sortIndex":83,"affiliation":2888,"properties":22},"8e9eb9e7-33c1-45d9-8f3e-bbdcb628481f",{"id":2887,"createTime":22,"updateTime":22,"relativeEntities":2889,"slug":22,"properties":2890,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2893,"statistic":22},[],{"title":2891},{"VI":2892},"Department of Urology, Ospedale Mater Salutis, Legnago, Italy",[],{"title":2895},{"VI":2896},"Pierpaolo Curti",{"url":2613,"publisher":2898,"properties":2940},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2899,"slug":10,"properties":2900,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":2904,"manageAffiliations":2909,"indexDatabases":2920,"url":81,"thumbnailPath":22,"statistic":2935,"gsStatistic":22,"type":22,"analyzePriority":22},[],{"issn":2901,"title":2902,"country":2903},{"VOID":15},{"EN":17},{"VOID":13},[2905],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":2906,"label":2907,"description":2908,"parentId":22,"standard":22,"scholarHubFieldId":22},[],{"EN":29},{},[2910,2915],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":2911,"slug":22,"properties":2912,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2914,"statistic":22},[],{"title":2913},{"EN":37},[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":2916,"slug":22,"properties":2917,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2919,"statistic":22},[],{"title":2918},{"EN":44},[],[2921,2928],{"id":48,"indexDatabase":2922,"url":61,"indexYears":22,"academicFieldIds":2927,"indexDatabaseRanking":22},{"id":50,"createTime":22,"updateTime":22,"relativeEntities":2923,"label":2924,"description":2925,"key":57,"publicationTags":2926,"standard":22},[],{"EN":53,"VI":53},{"EN":55,"VI":56},[59,60],[63],{"id":65,"indexDatabase":2929,"url":76,"indexYears":77,"academicFieldIds":2934,"indexDatabaseRanking":80},{"id":67,"createTime":22,"updateTime":22,"relativeEntities":2930,"label":2931,"description":2932,"key":73,"publicationTags":2933,"standard":22},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79],{"impactFactor":83,"impactFactorByYear":2936,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":2937,"totalCitation":83,"totalCitationByYear":2938,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":2939,"hindexLast5Year":83,"hindex":83},{},{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},{},{},{"pages":2941,"volume":2943},{"VOID":2942},"276-282",{"VOID":1158},"2022-01-01",[59,80],{"id":2947,"createTime":2948,"updateTime":2949,"relativeEntities":2950,"slug":2951,"properties":2952,"entityType":117,"verifyStatus":118,"verifyTime":2949,"verifyNote":120,"languages":22,"translateLanguages":22,"viewCount":83,"primaryUrl":2959,"fullTextUrl":22,"authors":2960,"publicationType":318,"publisherRelationship":3049,"citationCount":22,"citationInfo":22,"publishDate":3096,"publishYear":722,"citationAnalyzeStatus":21,"lastCitationAnalyze":22,"indexDatabases":3097,"openAccess":22,"references":22,"isForceReanalyzing":374},"b9194de9-3292-4f64-b556-16724a1351ff","2023-12-28T11:06:36.012+00:00","2025-02-27T00:13:38.365+00:00",[],"Reoperations-for-Female-Stress-Urinary-Incontinence-A-Finnish-National-Register-Study",{"title":2953,"references":2955,"doi":2957},{"EN":2954},"Reoperations for Female Stress Urinary Incontinence: A Finnish National Register Study",{"VOID":2956},"Haylen, 2010, An International Urogynecological Association (IUGA)\u002FInternational Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction, Int Urogynecol J, 21, 5, 10.1007\u002Fs00192-009-0976-9\nWood, 2014, Urinary incontinence in women, BMJ Br Med J, 349, 1\nWu, 2014, Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery, Obstet Gynecol, 123, 1201, 10.1097\u002FAOG.0000000000000286\nKurkijärvi, 2016, Surgery for stress urinary incontinence in Finland 1987–2009, Int Urogynecol J, 27, 1021, 10.1007\u002Fs00192-015-2926-z\nLapitan, 2016, Open retropubic colposuspension for urinary incontinence in women (systematic review), Cochrane Database Syst Rev, 2, 10.1002\u002F14651858.CD002912.pub6\nSchimpf, 2014, Sling surgery for stress urinary incontinence in women: A systematic review and metaanalysis, Am J Obstet Gynecol, 211, e1\nNilsson, 2013, Seventeen years’ follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence, Int Urogynecol J, 24, 1265, 10.1007\u002Fs00192-013-2090-2\nSerati, 2016, Tension-free vaginal tape–obturator for treatment of pure urodynamic stress urinary incontinence: efficacy and adverse effects at 10-year follow-up, Eur Urol, 71, 674, 10.1016\u002Fj.eururo.2016.08.054\nFord, 2015, Mid-urethral sling operations for stress urinary incontinence in women, Cochrane Database Syst Rev, 7, 10\nWu, 2015, Trends in reoperation for female stress urinary incontinence: a nationwide study, Neurourol Urodyn, 34, 693, 10.1002\u002Fnau.22648\nJonsson Funk, 2012, Long-term outcomes after stress urinary incontinence surgery, Obstet Gynecol, 120, 83, 10.1097\u002FAOG.0b013e318258fbde\nFialkow, 2008, Reoperation for urinary incontinence, Am J Obstet Gynecol, 199, e1\nHansen, 2015, Repeat surgery after failed midurethral slings: a nationwide cohort study, 1998–2007, Int Urogynecol J, 27, 1013, 10.1007\u002Fs00192-015-2925-0\nHansen, 2016, Reoperation for urinary incontinence: a nationwide cohort study, 1996–2007, Am J Obstet Gynecol, 214, e1\nAbdel-Fattah, 2011, Primary and repeat surgical treatment for female pelvic organ prolapse and incontinence in parous women in the UK: a register linkage study, BMJ Open, 1, e000206, 10.1136\u002Fbmjopen-2011-000206\nAigmueller, 2011, Ten-year follow-up after the tension-free vaginal tape procedure, Am J Obstet Gynecol, 205, e1\nSvenningsen, 2013, Long-term follow-up of the retropubic tension-free vaginal tape procedure, Int Urogynecol J, 24, 1271, 10.1007\u002Fs00192-013-2058-2\nRobinson, 2015, What is the best surgical intervention for stress urinary incontinence in the very young and very old? An International Consultation on Incontinence Research Society update, Int Urogynecol J, 26, 1599, 10.1007\u002Fs00192-015-2783-9\nRac, 2017, Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications, Neurourol Urodyn, 36, 1155, 10.1002\u002Fnau.23080\nHawkes, 2015, Cochrane reviews evidence on surgery for stress incontinence after controversy in Scotland, BMJ, 351, h3578, 10.1136\u002Fbmj.h3578\nWilkie, 2015",{"VOID":2958},"10.1016\u002Fj.euf.2017.05.005","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS2405456917301232",[2961,2985,3005,3029],{"id":2962,"sortIndex":83,"researcher":22,"roles":2963,"affiliations":2964,"properties":2982,"displayName":2984,"givenName":22,"familyName":22},"00c92113-c1a2-42f3-87d3-1e8c72a25f34",[126],[2965,2973],{"id":2966,"sortIndex":83,"affiliation":2967,"properties":22},"167afb27-3360-4fac-b691-0306207c0bb4",{"id":2966,"createTime":22,"updateTime":22,"relativeEntities":2968,"slug":22,"properties":2969,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2972,"statistic":22},[],{"title":2970},{"VI":2971},"Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland",[],{"id":2974,"sortIndex":141,"affiliation":2975,"properties":2981},"8eb9fe67-e8ac-4f6e-bbe8-07235cd82d2e",{"id":2974,"createTime":22,"updateTime":22,"relativeEntities":2976,"slug":22,"properties":2977,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2980,"statistic":22},[],{"title":2978},{"VI":2979},"Obstetrics and Gynecology, University of Turku, Medical Faculty, Clinical Division, Turku, Finland",[],{},{"title":2983},{"VI":2984},"Kaisa Kurkijärvi",{"id":2986,"sortIndex":141,"researcher":22,"roles":2987,"affiliations":2988,"properties":3002,"displayName":3004,"givenName":22,"familyName":22},"7772f4b6-48ed-4ddd-ace6-ad6bf2c78bb4",[126],[2989,2995],{"id":2966,"sortIndex":83,"affiliation":2990,"properties":22},{"id":2966,"createTime":22,"updateTime":22,"relativeEntities":2991,"slug":22,"properties":2992,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":2994,"statistic":22},[],{"title":2993},{"VI":2971},[],{"id":2974,"sortIndex":141,"affiliation":2996,"properties":3001},{"id":2974,"createTime":22,"updateTime":22,"relativeEntities":2997,"slug":22,"properties":2998,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":3000,"statistic":22},[],{"title":2999},{"VI":2979},[],{},{"title":3003},{"VI":3004},"Riikka Aaltonen",{"id":3006,"sortIndex":165,"researcher":22,"roles":3007,"affiliations":3008,"properties":3026,"displayName":3028,"givenName":22,"familyName":22},"1aafdc70-69f1-484a-bd90-28de8d4d5ba2",[126],[3009,3017],{"id":3010,"sortIndex":83,"affiliation":3011,"properties":22},"cbeb811c-5663-435a-9a9a-1aab44f4a979",{"id":3010,"createTime":22,"updateTime":22,"relativeEntities":3012,"slug":22,"properties":3013,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":3016,"statistic":22},[],{"title":3014},{"VI":3015},"National Institute for Health and Welfare, Helsinki, Finland",[],{"id":3018,"sortIndex":141,"affiliation":3019,"properties":3025},"479b3bd4-ae6d-4f17-9d48-e88de661c31a",{"id":3018,"createTime":22,"updateTime":22,"relativeEntities":3020,"slug":22,"properties":3021,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":3024,"statistic":22},[],{"title":3022},{"VI":3023},"Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Division of Family Medicine, Stockholm, Sweden",[],{},{"title":3027},{"VI":3028},"Mika Gissler",{"id":3030,"sortIndex":197,"researcher":22,"roles":3031,"affiliations":3032,"properties":3046,"displayName":3048,"givenName":22,"familyName":22},"882a03dd-e68a-4e32-afac-9bbd328d8466",[126],[3033,3039],{"id":2966,"sortIndex":83,"affiliation":3034,"properties":22},{"id":2966,"createTime":22,"updateTime":22,"relativeEntities":3035,"slug":22,"properties":3036,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":3038,"statistic":22},[],{"title":3037},{"VI":2971},[],{"id":2974,"sortIndex":141,"affiliation":3040,"properties":3045},{"id":2974,"createTime":22,"updateTime":22,"relativeEntities":3041,"slug":22,"properties":3042,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":3044,"statistic":22},[],{"title":3043},{"VI":2979},[],{},{"title":3047},{"VI":3048},"Juha Mäkinen",{"url":2959,"publisher":3050,"properties":3092},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":3051,"slug":10,"properties":3052,"entityType":20,"verifyStatus":21,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":23,"subjectFields":3056,"manageAffiliations":3061,"indexDatabases":3072,"url":81,"thumbnailPath":22,"statistic":3087,"gsStatistic":22,"type":22,"analyzePriority":22},[],{"issn":3053,"title":3054,"country":3055},{"VOID":15},{"EN":17},{"VOID":13},[3057],{"id":26,"createTime":22,"updateTime":22,"relativeEntities":3058,"label":3059,"description":3060,"parentId":22,"standard":22,"scholarHubFieldId":22},[],{"EN":29},{},[3062,3067],{"id":33,"createTime":22,"updateTime":22,"relativeEntities":3063,"slug":22,"properties":3064,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":3066,"statistic":22},[],{"title":3065},{"EN":37},[],{"id":40,"createTime":22,"updateTime":22,"relativeEntities":3068,"slug":22,"properties":3069,"entityType":22,"verifyStatus":22,"verifyTime":22,"verifyNote":22,"languages":22,"translateLanguages":22,"viewCount":22,"url":22,"parentIds":3071,"statistic":22},[],{"title":3070},{"EN":44},[],[3073,3080],{"id":48,"indexDatabase":3074,"url":61,"indexYears":22,"academicFieldIds":3079,"indexDatabaseRanking":22},{"id":50,"createTime":22,"updateTime":22,"relativeEntities":3075,"label":3076,"description":3077,"key":57,"publicationTags":3078,"standard":22},[],{"EN":53,"VI":53},{"EN":55,"VI":56},[59,60],[63],{"id":65,"indexDatabase":3081,"url":76,"indexYears":77,"academicFieldIds":3086,"indexDatabaseRanking":80},{"id":67,"createTime":22,"updateTime":22,"relativeEntities":3082,"label":3083,"description":3084,"key":73,"publicationTags":3085,"standard":22},[],{"EN":70,"VI":70},{"EN":70,"VI":72},[75],[79],{"impactFactor":83,"impactFactorByYear":3088,"i10Index":83,"i10IndexLast5Year":83,"totalPublication":85,"totalPublicationByYear":3089,"totalCitation":83,"totalCitationByYear":3090,"totalCitationPerPublication":83,"totalCitationPerPublicationByYear":3091,"hindexLast5Year":83,"hindex":83},{},{"2015":87,"2016":88,"2017":89,"2018":90,"2019":91,"2020":92,"2021":93,"2022":94,"2023":95},{},{},{"pages":3093,"volume":3095},{"VOID":3094},"754-759",{"VOID":719},"2018-09-01",[59,80]]